Using Config: cfg_pubmed_v2_1.cfg
Runnin subconfig: HDPLDApubmed1PU
# topics: 1000
Using dataset: corpora/pubmed.txt
Scheme: ppu_hdplda_all_topics
100000
200000
300000
400000
500000
600000
700000
800000
900000
1000000
1100000
1200000
1300000
1400000
1500000
1600000
1700000
1800000
1900000
2000000
2100000
2200000
2300000
2400000
2500000
2600000
2700000
2800000
2900000
3000000
3100000
3200000
3300000
3400000
3500000
3600000
3700000
3800000
3900000
4000000
4100000
4200000
4300000
4400000
4500000
4600000
4700000
4800000
4900000
5000000
5100000
5200000
5300000
5400000
5500000
5600000
5700000
5800000
5900000
6000000
6100000
6200000
6300000
6400000
6500000
6600000
6700000
6800000
6900000
7000000
7100000
7200000
7300000
7400000
7500000
7600000
7700000
7800000
7900000
8000000
8100000
HDP gamma: 1.0
HDP start topics: 1
PoissonPolyaUrnHDPLDAInfiniteTopics Parallell HDP.
Rare word threshold: 10
Vocabulary size: 89987

Instance list is: 8199999
Loading data instances...
Config seed:4711
Start seed: 4711
Loaded 8199999 documents, with 768434972 words in total.
Starting iterations (25000 total).
_____________________________

Starting:Mon May 20 16:04:21 BST 2019
Active in data: 16	K = 0	Empty topics (984)
<100> Log Likelihood: -7.775446268556805E9
Active in data: 17	K = 1	Empty topics (983)
<200> Log Likelihood: -7.721544230287488E9
Active in data: 17	K = 3	Empty topics (983)
<300> Log Likelihood: -7.679090388619397E9
Active in data: 17	K = 4	Empty topics (983)
<400> Log Likelihood: -7.64033353290705E9
Active in data: 18	K = 5	Empty topics (982)
<500> Log Likelihood: -7.604980602044574E9
Active in data: 18	K = 6	Empty topics (982)
<600> Log Likelihood: -7.579233904156134E9
Active in data: 18	K = 6	Empty topics (982)
<700> Log Likelihood: -7.552523610766253E9
Active in data: 19	K = 7	Empty topics (981)
<800> Log Likelihood: -7.53271831859757E9
Active in data: 19	K = 7	Empty topics (981)
<900> Log Likelihood: -7.517313451119304E9
Active in data: 19	K = 7	Empty topics (981)
<1000> Log Likelihood: -7.505330288612247E9
Active in data: 19	K = 8	Empty topics (981)
<1100> Log Likelihood: -7.496659696934978E9
Active in data: 20	K = 8	Empty topics (980)
<1200> Log Likelihood: -7.489947369188693E9
Active in data: 20	K = 8	Empty topics (980)
<1300> Log Likelihood: -7.484747119062607E9
Active in data: 20	K = 9	Empty topics (980)
<1400> Log Likelihood: -7.48163635395877E9
Active in data: 20	K = 9	Empty topics (980)
<1500> Log Likelihood: -7.479719717863082E9
Active in data: 22	K = 9	Empty topics (978)
<1600> Log Likelihood: -7.477740282340377E9
Active in data: 21	K = 9	Empty topics (979)
<1700> Log Likelihood: -7.475336119257847E9
Active in data: 22	K = 9	Empty topics (978)
<1800> Log Likelihood: -7.472719329912012E9
Active in data: 22	K = 9	Empty topics (978)
<1900> Log Likelihood: -7.4698883577689495E9
Active in data: 22	K = 9	Empty topics (978)
<2000> Log Likelihood: -7.466800758997786E9
Active in data: 22	K = 9	Empty topics (978)
<2100> Log Likelihood: -7.463919033599831E9
Active in data: 22	K = 10	Empty topics (978)
<2200> Log Likelihood: -7.460708963539586E9
Active in data: 21	K = 10	Empty topics (979)
<2300> Log Likelihood: -7.4578711125448675E9
Active in data: 22	K = 10	Empty topics (978)
<2400> Log Likelihood: -7.454899130914279E9
Active in data: 23	K = 10	Empty topics (977)
<2500> Log Likelihood: -7.452403294926978E9
Active in data: 25	K = 10	Empty topics (975)
<2600> Log Likelihood: -7.450810483772117E9
Active in data: 25	K = 10	Empty topics (975)
<2700> Log Likelihood: -7.44985926587162E9
Active in data: 25	K = 11	Empty topics (975)
<2800> Log Likelihood: -7.449064837359886E9
Active in data: 26	K = 11	Empty topics (974)
<2900> Log Likelihood: -7.448309369445779E9
Active in data: 26	K = 11	Empty topics (974)
<3000> Log Likelihood: -7.447554658135253E9
Active in data: 26	K = 11	Empty topics (974)
<3100> Log Likelihood: -7.447059958339947E9
Active in data: 26	K = 11	Empty topics (974)
<3200> Log Likelihood: -7.446619796407559E9
Active in data: 26	K = 11	Empty topics (974)
<3300> Log Likelihood: -7.446313352553313E9
Active in data: 26	K = 11	Empty topics (974)
<3400> Log Likelihood: -7.4459848427771E9
Active in data: 26	K = 11	Empty topics (974)
<3500> Log Likelihood: -7.445502378114602E9
Active in data: 25	K = 11	Empty topics (975)
<3600> Log Likelihood: -7.444522132673524E9
Active in data: 25	K = 11	Empty topics (975)
<3700> Log Likelihood: -7.442833895794288E9
Active in data: 25	K = 11	Empty topics (975)
<3800> Log Likelihood: -7.440368750513216E9
Active in data: 26	K = 11	Empty topics (974)
<3900> Log Likelihood: -7.438580146595981E9
Active in data: 25	K = 11	Empty topics (975)
<4000> Log Likelihood: -7.437842161582519E9
Active in data: 26	K = 11	Empty topics (974)
<4100> Log Likelihood: -7.4372519833812E9
Active in data: 27	K = 11	Empty topics (973)
<4200> Log Likelihood: -7.436415181507027E9
Active in data: 27	K = 11	Empty topics (973)
<4300> Log Likelihood: -7.435239669574427E9
Active in data: 27	K = 11	Empty topics (973)
<4400> Log Likelihood: -7.433413919861726E9
Active in data: 27	K = 11	Empty topics (973)
<4500> Log Likelihood: -7.430912567280669E9
Active in data: 27	K = 11	Empty topics (973)
<4600> Log Likelihood: -7.427900181196456E9
Active in data: 29	K = 11	Empty topics (971)
<4700> Log Likelihood: -7.424887103154825E9
Active in data: 29	K = 12	Empty topics (971)
<4800> Log Likelihood: -7.422473074173475E9
Active in data: 32	K = 12	Empty topics (968)
<4900> Log Likelihood: -7.420612746370896E9
Active in data: 28	K = 12	Empty topics (972)
<5000> Log Likelihood: -7.418940574271162E9
Active in data: 27	K = 12	Empty topics (973)
<5100> Log Likelihood: -7.417159434131921E9
Active in data: 28	K = 12	Empty topics (972)
<5200> Log Likelihood: -7.415534203398649E9
Active in data: 28	K = 12	Empty topics (972)
<5300> Log Likelihood: -7.414208481351966E9
Active in data: 28	K = 12	Empty topics (972)
<5400> Log Likelihood: -7.412563946438906E9
Active in data: 28	K = 13	Empty topics (972)
<5500> Log Likelihood: -7.410657029583958E9
Active in data: 29	K = 13	Empty topics (971)
<5600> Log Likelihood: -7.408970105535921E9
Active in data: 29	K = 13	Empty topics (971)
<5700> Log Likelihood: -7.407424341821774E9
Active in data: 30	K = 13	Empty topics (970)
<5800> Log Likelihood: -7.406139122046588E9
Active in data: 29	K = 13	Empty topics (971)
<5900> Log Likelihood: -7.404913149316363E9
Active in data: 28	K = 13	Empty topics (972)
<6000> Log Likelihood: -7.403780210179303E9
Active in data: 29	K = 13	Empty topics (971)
<6100> Log Likelihood: -7.402548043225723E9
Active in data: 28	K = 13	Empty topics (972)
<6200> Log Likelihood: -7.401282596053551E9
Active in data: 28	K = 14	Empty topics (972)
<6300> Log Likelihood: -7.400000626331024E9
Active in data: 29	K = 14	Empty topics (971)
<6400> Log Likelihood: -7.398753808570829E9
Active in data: 28	K = 14	Empty topics (972)
<6500> Log Likelihood: -7.396826862147949E9
Active in data: 29	K = 14	Empty topics (971)
<6600> Log Likelihood: -7.394720233015227E9
Active in data: 28	K = 14	Empty topics (972)
<6700> Log Likelihood: -7.392889699273384E9
Active in data: 28	K = 14	Empty topics (972)
<6800> Log Likelihood: -7.391577229549694E9
Active in data: 28	K = 14	Empty topics (972)
<6900> Log Likelihood: -7.390283636999722E9
Active in data: 28	K = 14	Empty topics (972)
<7000> Log Likelihood: -7.388861327190968E9
Active in data: 28	K = 14	Empty topics (972)
<7100> Log Likelihood: -7.386874955300642E9
Active in data: 29	K = 15	Empty topics (971)
<7200> Log Likelihood: -7.384399266372937E9
Active in data: 30	K = 15	Empty topics (970)
<7300> Log Likelihood: -7.381817441432156E9
Active in data: 29	K = 15	Empty topics (971)
<7400> Log Likelihood: -7.379407299042138E9
Active in data: 29	K = 15	Empty topics (971)
<7500> Log Likelihood: -7.377114157855119E9
Active in data: 29	K = 15	Empty topics (971)
<7600> Log Likelihood: -7.374987832359793E9
Active in data: 30	K = 15	Empty topics (970)
<7700> Log Likelihood: -7.372975402540402E9
Active in data: 31	K = 15	Empty topics (969)
<7800> Log Likelihood: -7.371347597821266E9
Active in data: 31	K = 15	Empty topics (969)
<7900> Log Likelihood: -7.369877932508137E9
Active in data: 32	K = 16	Empty topics (968)
<8000> Log Likelihood: -7.368630359458642E9
Active in data: 33	K = 16	Empty topics (967)
<8100> Log Likelihood: -7.367703459096129E9
Active in data: 31	K = 16	Empty topics (969)
<8200> Log Likelihood: -7.367092517771974E9
Active in data: 32	K = 16	Empty topics (968)
<8300> Log Likelihood: -7.366710038146347E9
Active in data: 32	K = 16	Empty topics (968)
<8400> Log Likelihood: -7.366495804557681E9
Active in data: 34	K = 16	Empty topics (966)
<8500> Log Likelihood: -7.366227739846502E9
Active in data: 32	K = 16	Empty topics (968)
<8600> Log Likelihood: -7.365887651212564E9
Active in data: 33	K = 16	Empty topics (967)
<8700> Log Likelihood: -7.365497143758774E9
Active in data: 35	K = 16	Empty topics (965)
<8800> Log Likelihood: -7.365061107377089E9
Active in data: 34	K = 16	Empty topics (966)
<8900> Log Likelihood: -7.364575968181371E9
Active in data: 34	K = 16	Empty topics (966)
<9000> Log Likelihood: -7.363897345472615E9
Active in data: 34	K = 17	Empty topics (966)
<9100> Log Likelihood: -7.363278144780608E9
Active in data: 35	K = 17	Empty topics (965)
<9200> Log Likelihood: -7.362743036172785E9
Active in data: 34	K = 17	Empty topics (966)
<9300> Log Likelihood: -7.36213630639236E9
Active in data: 35	K = 17	Empty topics (965)
<9400> Log Likelihood: -7.361614744617234E9
Active in data: 36	K = 17	Empty topics (964)
<9500> Log Likelihood: -7.361193917507138E9
Active in data: 35	K = 17	Empty topics (965)
<9600> Log Likelihood: -7.360770243078253E9
Active in data: 35	K = 17	Empty topics (965)
<9700> Log Likelihood: -7.360362091762631E9
Active in data: 35	K = 17	Empty topics (965)
<9800> Log Likelihood: -7.360047932919539E9
Active in data: 35	K = 17	Empty topics (965)
<9900> Log Likelihood: -7.3597849209616585E9
Active in data: 36	K = 17	Empty topics (964)
<10000> Log Likelihood: -7.359375782049171E9
Active in data: 35	K = 17	Empty topics (965)
<10100> Log Likelihood: -7.358904208753769E9
Active in data: 35	K = 17	Empty topics (965)
<10200> Log Likelihood: -7.358395544969975E9
Active in data: 36	K = 17	Empty topics (964)
<10300> Log Likelihood: -7.357935276252704E9
Active in data: 35	K = 17	Empty topics (965)
<10400> Log Likelihood: -7.357577389872289E9
Active in data: 37	K = 17	Empty topics (963)
<10500> Log Likelihood: -7.357112871442004E9
Active in data: 37	K = 17	Empty topics (963)
<10600> Log Likelihood: -7.356685408579774E9
Active in data: 37	K = 17	Empty topics (963)
<10700> Log Likelihood: -7.356227007157684E9
Active in data: 39	K = 18	Empty topics (961)
<10800> Log Likelihood: -7.35576400560964E9
Active in data: 37	K = 18	Empty topics (963)
<10900> Log Likelihood: -7.355248309959842E9
Active in data: 37	K = 18	Empty topics (963)
<11000> Log Likelihood: -7.354701767360626E9
Active in data: 37	K = 18	Empty topics (963)
<11100> Log Likelihood: -7.354181536757131E9
Active in data: 37	K = 18	Empty topics (963)
<11200> Log Likelihood: -7.353575245173554E9
Active in data: 37	K = 18	Empty topics (963)
<11300> Log Likelihood: -7.353132279608989E9
Active in data: 37	K = 18	Empty topics (963)
<11400> Log Likelihood: -7.352688561037623E9
Active in data: 38	K = 18	Empty topics (962)
<11500> Log Likelihood: -7.352172060850453E9
Active in data: 37	K = 18	Empty topics (963)
<11600> Log Likelihood: -7.3514613431299515E9
Active in data: 38	K = 18	Empty topics (962)
<11700> Log Likelihood: -7.350626978454269E9
Active in data: 38	K = 18	Empty topics (962)
<11800> Log Likelihood: -7.349682288092145E9
Active in data: 39	K = 18	Empty topics (961)
<11900> Log Likelihood: -7.348723793985909E9
Active in data: 38	K = 18	Empty topics (962)
<12000> Log Likelihood: -7.347646794599301E9
Active in data: 39	K = 18	Empty topics (961)
<12100> Log Likelihood: -7.346445848259329E9
Active in data: 37	K = 18	Empty topics (963)
<12200> Log Likelihood: -7.345342864351104E9
Active in data: 39	K = 18	Empty topics (961)
<12300> Log Likelihood: -7.344232373147169E9
Active in data: 39	K = 18	Empty topics (961)
<12400> Log Likelihood: -7.343230265179502E9
Active in data: 37	K = 18	Empty topics (963)
<12500> Log Likelihood: -7.342131377432005E9
Active in data: 38	K = 18	Empty topics (962)
<12600> Log Likelihood: -7.341090681775734E9
Active in data: 39	K = 19	Empty topics (961)
<12700> Log Likelihood: -7.340039574170028E9
Active in data: 40	K = 19	Empty topics (960)
<12800> Log Likelihood: -7.339061146523396E9
Active in data: 40	K = 19	Empty topics (960)
<12900> Log Likelihood: -7.338215735195787E9
Active in data: 39	K = 19	Empty topics (961)
<13000> Log Likelihood: -7.337357684568669E9
Active in data: 40	K = 19	Empty topics (960)
<13100> Log Likelihood: -7.3367323258449335E9
Active in data: 40	K = 19	Empty topics (960)
<13200> Log Likelihood: -7.336212654857897E9
Active in data: 41	K = 19	Empty topics (959)
<13300> Log Likelihood: -7.335776994118442E9
Active in data: 40	K = 19	Empty topics (960)
<13400> Log Likelihood: -7.3353901026486025E9
Active in data: 41	K = 19	Empty topics (959)
<13500> Log Likelihood: -7.334988312364931E9
Active in data: 41	K = 19	Empty topics (959)
<13600> Log Likelihood: -7.334621675994104E9
Active in data: 41	K = 19	Empty topics (959)
<13700> Log Likelihood: -7.3342125310311775E9
Active in data: 41	K = 19	Empty topics (959)
<13800> Log Likelihood: -7.333734532720806E9
Active in data: 40	K = 19	Empty topics (960)
<13900> Log Likelihood: -7.333275294380641E9
Active in data: 40	K = 19	Empty topics (960)
<14000> Log Likelihood: -7.332665974281862E9
Active in data: 40	K = 19	Empty topics (960)
<14100> Log Likelihood: -7.33199857536616E9
Active in data: 43	K = 19	Empty topics (957)
<14200> Log Likelihood: -7.331151080584098E9
Active in data: 42	K = 20	Empty topics (958)
<14300> Log Likelihood: -7.330279287733959E9
Active in data: 41	K = 20	Empty topics (959)
<14400> Log Likelihood: -7.329377438961685E9
Active in data: 41	K = 20	Empty topics (959)
<14500> Log Likelihood: -7.328349400199667E9
Active in data: 42	K = 20	Empty topics (958)
<14600> Log Likelihood: -7.327310172343823E9
Active in data: 41	K = 20	Empty topics (959)
<14700> Log Likelihood: -7.326088415981724E9
Active in data: 41	K = 20	Empty topics (959)
<14800> Log Likelihood: -7.324621263774131E9
Active in data: 40	K = 20	Empty topics (960)
<14900> Log Likelihood: -7.323239312434572E9
Active in data: 40	K = 20	Empty topics (960)
<15000> Log Likelihood: -7.3218109835960655E9
Active in data: 40	K = 20	Empty topics (960)
<15100> Log Likelihood: -7.320528202145043E9
Active in data: 40	K = 20	Empty topics (960)
<15200> Log Likelihood: -7.319351547407234E9
Active in data: 41	K = 21	Empty topics (959)
<15300> Log Likelihood: -7.318156043322969E9
Active in data: 42	K = 21	Empty topics (958)
<15400> Log Likelihood: -7.316969129883313E9
Active in data: 41	K = 21	Empty topics (959)
<15500> Log Likelihood: -7.315768884373611E9
Active in data: 41	K = 21	Empty topics (959)
<15600> Log Likelihood: -7.314666476711245E9
Active in data: 43	K = 21	Empty topics (957)
<15700> Log Likelihood: -7.313582591932534E9
Active in data: 43	K = 21	Empty topics (957)
<15800> Log Likelihood: -7.312610797078062E9
Active in data: 42	K = 21	Empty topics (958)
<15900> Log Likelihood: -7.31177794186463E9
Active in data: 42	K = 21	Empty topics (958)
<16000> Log Likelihood: -7.311011897824028E9
Active in data: 42	K = 21	Empty topics (958)
<16100> Log Likelihood: -7.310192106400077E9
Active in data: 42	K = 22	Empty topics (958)
<16200> Log Likelihood: -7.30950583508209E9
Active in data: 43	K = 22	Empty topics (957)
<16300> Log Likelihood: -7.308845837693704E9
Active in data: 43	K = 22	Empty topics (957)
<16400> Log Likelihood: -7.308174700756244E9
Active in data: 41	K = 22	Empty topics (959)
<16500> Log Likelihood: -7.307626307634921E9
Active in data: 41	K = 22	Empty topics (959)
<16600> Log Likelihood: -7.307007680313472E9
Active in data: 43	K = 22	Empty topics (957)
<16700> Log Likelihood: -7.306489900095715E9
Active in data: 43	K = 22	Empty topics (957)
<16800> Log Likelihood: -7.306000224782836E9
Active in data: 44	K = 22	Empty topics (956)
<16900> Log Likelihood: -7.30579776700622E9
Active in data: 43	K = 22	Empty topics (957)
<17000> Log Likelihood: -7.305557716796207E9
Active in data: 45	K = 22	Empty topics (955)
<17100> Log Likelihood: -7.305429338094997E9
Active in data: 45	K = 22	Empty topics (955)
<17200> Log Likelihood: -7.305339913966831E9
Active in data: 45	K = 22	Empty topics (955)
<17300> Log Likelihood: -7.305197057450823E9
Active in data: 45	K = 22	Empty topics (955)
<17400> Log Likelihood: -7.305034228018574E9
Active in data: 47	K = 22	Empty topics (953)
<17500> Log Likelihood: -7.304849540515728E9
Active in data: 45	K = 22	Empty topics (955)
<17600> Log Likelihood: -7.304478301414302E9
Active in data: 46	K = 22	Empty topics (954)
<17700> Log Likelihood: -7.3041163827987385E9
Active in data: 46	K = 23	Empty topics (954)
<17800> Log Likelihood: -7.303770932526501E9
Active in data: 45	K = 23	Empty topics (955)
<17900> Log Likelihood: -7.303361181167112E9
Active in data: 45	K = 23	Empty topics (955)
<18000> Log Likelihood: -7.302879459634111E9
Active in data: 45	K = 23	Empty topics (955)
<18100> Log Likelihood: -7.302376851699024E9
Active in data: 46	K = 23	Empty topics (954)
<18200> Log Likelihood: -7.301886376021467E9
Active in data: 45	K = 23	Empty topics (955)
<18300> Log Likelihood: -7.301259852614442E9
Active in data: 45	K = 23	Empty topics (955)
<18400> Log Likelihood: -7.300733605724999E9
Active in data: 46	K = 23	Empty topics (954)
<18500> Log Likelihood: -7.300160158896577E9
Active in data: 47	K = 23	Empty topics (953)
<18600> Log Likelihood: -7.299602326020157E9
Active in data: 45	K = 23	Empty topics (955)
<18700> Log Likelihood: -7.299089713037476E9
Active in data: 45	K = 23	Empty topics (955)
<18800> Log Likelihood: -7.298536887951593E9
Active in data: 45	K = 23	Empty topics (955)
<18900> Log Likelihood: -7.297926012240545E9
Active in data: 45	K = 23	Empty topics (955)
<19000> Log Likelihood: -7.297338255386766E9
Active in data: 47	K = 23	Empty topics (953)
<19100> Log Likelihood: -7.296680070122668E9
Active in data: 46	K = 23	Empty topics (954)
<19200> Log Likelihood: -7.29605858747072E9
Active in data: 48	K = 23	Empty topics (952)
<19300> Log Likelihood: -7.295401354804809E9
Active in data: 48	K = 23	Empty topics (952)
<19400> Log Likelihood: -7.294747944582752E9
Active in data: 47	K = 24	Empty topics (953)
<19500> Log Likelihood: -7.294070345698896E9
Active in data: 48	K = 24	Empty topics (952)
<19600> Log Likelihood: -7.293387780297174E9
Active in data: 47	K = 24	Empty topics (953)
<19700> Log Likelihood: -7.292743181567119E9
Active in data: 47	K = 24	Empty topics (953)
<19800> Log Likelihood: -7.292077526837624E9
Active in data: 48	K = 24	Empty topics (952)
<19900> Log Likelihood: -7.291477026779739E9
Active in data: 48	K = 24	Empty topics (952)
<20000> Log Likelihood: -7.29082712595905E9
Active in data: 48	K = 24	Empty topics (952)
<20100> Log Likelihood: -7.290228162699626E9
Active in data: 48	K = 24	Empty topics (952)
<20200> Log Likelihood: -7.289503565771412E9
Active in data: 49	K = 24	Empty topics (951)
<20300> Log Likelihood: -7.288868519970517E9
Active in data: 49	K = 24	Empty topics (951)
<20400> Log Likelihood: -7.28822423069637E9
Active in data: 49	K = 24	Empty topics (951)
<20500> Log Likelihood: -7.287716801398169E9
Active in data: 50	K = 24	Empty topics (950)
<20600> Log Likelihood: -7.287350998154607E9
Active in data: 48	K = 24	Empty topics (952)
<20700> Log Likelihood: -7.28705850974471E9
Active in data: 49	K = 24	Empty topics (951)
<20800> Log Likelihood: -7.286589786615604E9
Active in data: 48	K = 24	Empty topics (952)
<20900> Log Likelihood: -7.285993989930997E9
Active in data: 48	K = 24	Empty topics (952)
<21000> Log Likelihood: -7.285155223064126E9
Active in data: 48	K = 25	Empty topics (952)
<21100> Log Likelihood: -7.283957337349165E9
Active in data: 48	K = 25	Empty topics (952)
<21200> Log Likelihood: -7.28276327773828E9
Active in data: 48	K = 25	Empty topics (952)
<21300> Log Likelihood: -7.281710258813376E9
Active in data: 48	K = 25	Empty topics (952)
<21400> Log Likelihood: -7.280775655628058E9
Active in data: 48	K = 25	Empty topics (952)
<21500> Log Likelihood: -7.279963397831183E9
Active in data: 48	K = 25	Empty topics (952)
<21600> Log Likelihood: -7.279391941310007E9
Active in data: 48	K = 25	Empty topics (952)
<21700> Log Likelihood: -7.278867240155325E9
Active in data: 47	K = 25	Empty topics (953)
<21800> Log Likelihood: -7.278367909622126E9
Active in data: 48	K = 25	Empty topics (952)
<21900> Log Likelihood: -7.27789077572491E9
Active in data: 48	K = 25	Empty topics (952)
<22000> Log Likelihood: -7.277519630665159E9
Active in data: 50	K = 25	Empty topics (950)
<22100> Log Likelihood: -7.277088389958288E9
Active in data: 48	K = 25	Empty topics (952)
<22200> Log Likelihood: -7.276577069269365E9
Active in data: 48	K = 25	Empty topics (952)
<22300> Log Likelihood: -7.276128485159616E9
Active in data: 48	K = 25	Empty topics (952)
<22400> Log Likelihood: -7.275615989893813E9
Active in data: 48	K = 25	Empty topics (952)
<22500> Log Likelihood: -7.275174836452593E9
Active in data: 49	K = 25	Empty topics (951)
<22600> Log Likelihood: -7.274599983800937E9
Active in data: 50	K = 25	Empty topics (950)
<22700> Log Likelihood: -7.274142537844947E9
Active in data: 49	K = 25	Empty topics (951)
<22800> Log Likelihood: -7.273560787921003E9
Active in data: 51	K = 26	Empty topics (949)
<22900> Log Likelihood: -7.2729780534039955E9
Active in data: 48	K = 26	Empty topics (952)
<23000> Log Likelihood: -7.27230734622817E9
Active in data: 48	K = 26	Empty topics (952)
<23100> Log Likelihood: -7.271619320054529E9
Active in data: 48	K = 26	Empty topics (952)
<23200> Log Likelihood: -7.270868740021104E9
Active in data: 50	K = 26	Empty topics (950)
<23300> Log Likelihood: -7.270116132668471E9
Active in data: 50	K = 26	Empty topics (950)
<23400> Log Likelihood: -7.269290734985395E9
Active in data: 49	K = 26	Empty topics (951)
<23500> Log Likelihood: -7.268477294496616E9
Active in data: 51	K = 26	Empty topics (949)
<23600> Log Likelihood: -7.267788718562261E9
Active in data: 51	K = 26	Empty topics (949)
<23700> Log Likelihood: -7.267109211705803E9
Active in data: 51	K = 27	Empty topics (949)
<23800> Log Likelihood: -7.266469484125482E9
Active in data: 52	K = 27	Empty topics (948)
<23900> Log Likelihood: -7.265876294442332E9
Active in data: 52	K = 27	Empty topics (948)
<24000> Log Likelihood: -7.26520245533881E9
Active in data: 52	K = 27	Empty topics (948)
<24100> Log Likelihood: -7.264475713970034E9
Active in data: 54	K = 27	Empty topics (946)
<24200> Log Likelihood: -7.263614963341541E9
Active in data: 53	K = 27	Empty topics (947)
<24300> Log Likelihood: -7.262662507295283E9
Active in data: 52	K = 27	Empty topics (948)
<24400> Log Likelihood: -7.261661382176199E9
Active in data: 52	K = 27	Empty topics (948)
<24500> Log Likelihood: -7.260638012992234E9
Active in data: 52	K = 27	Empty topics (948)
<24600> Log Likelihood: -7.259650859647528E9
Active in data: 53	K = 27	Empty topics (947)
<24700> Log Likelihood: -7.258843268390706E9
Active in data: 54	K = 27	Empty topics (946)
<24800> Log Likelihood: -7.258019475475476E9
Active in data: 54	K = 27	Empty topics (946)
<24900> Log Likelihood: -7.257203693420951E9
Active in data: 53	K = 27	Empty topics (947)
<25000> Log Likelihood: -7.256519265664947E9
Finished:Fri May 24 04:12:26 BST 2019
Top words are: 
Topic 1: care health patient medical research clinical system hospital cost program physician data information practice problem management treatment development based quality
Topic 2: age risk year children women patient factor population health data disorder prevalence ci symptom mortality control smoking level analysis adult
Topic 3: gene protein dna expression sequence genes region rna sequences acid mutant cell mrna promoter transcription analysis human amino binding cdna
Topic 4: model data system analysis measurement time based parameter field distribution values test function effect set dynamic number technique approach error
Topic 5: patient treatment therapy drug effect mg trial dose day clinical month placebo week treated efficacy response randomized controlled pain effective
Topic 6: patient surgery surgical complication treatment year postoperative operation procedure month vein technique catheter graft underwent treated operative day artery follow
Topic 7: cancer tumor patient carcinoma cell breast survival tumour year malignant disease stage prostate primary treatment lesion lung chemotherapy metastases lymph
Topic 8: cell growth expression human factor effect beta lines culture tumor mrna protein endothelial proliferation vitro fibroblast level receptor line cultured
Topic 9: cell il cd mice alpha expression lymphocytes gamma immune antigen response human tnf ifn receptor production beta macrophages interleukin blood
Topic 10: patient disease clinical syndrome diagnosis year disorder treatment symptom lesion children chronic acute diseases severe therapy features presented common rare
Topic 11: cell neuron electron rat microscopy layer brain fiber development distribution region tissue nerve membrane axon number nucleus pattern staining day
Topic 12: binding protein structure interaction acid site reaction complex residues form chain domain ligand complexes structural peptide beta formation amino crystal
Topic 13: protein cell kinase receptor expression activation pathway factor phosphorylation activity signaling binding induced apoptosis function domain signal mechanism tyrosine gene
Topic 14: ca receptor channel cell effect calcium concentration na current microm membrane induced dependent release rat potential intracellular activity action muscle
Topic 15: concentration water samples solution liquid acid degrees ph phase chromatography detection system analysis determination mass surface effect drug material compound
Topic 16: acid activity enzyme liver rat effect concentration cell metabolism oxygen lipid enzymes glucose oxidative mitochondrial level cytochrome dehydrogenase inhibition synthesis
Topic 17: task effect visual memory sleep test response performance control movement activity responses stimuli stimulus function experiment hearing cortex frequency brain
Topic 18: blood pressure flow effect rat arterial hypertension min vascular control heart renal ischemia angiotensin hypertensive infusion ii induced rate artery
Topic 19: bone patient joint implant fractures treatment fracture hip year dental tissue knee teeth cartilage clinical mm anterior flap femoral mineral
Topic 20: protein binding activity acid gel enzyme alpha purified membrane molecular human fraction kda cell beta form amino chromatography weight subunit
Topic 21: rat mice effect day mg dose animal kg liver induced exposure administration treatment control injection level treated doses ethanol model
Topic 22: patient heart coronary ventricular myocardial cardiac left artery infarction disease atrial valve failure acute aortic function year mitral rate echocardiography
Topic 23: receptor rat effect brain neuron dopamine induced antagonist activity kg mg system nucleus agonist level ht administration opioid morphine injection
Topic 24: mutation gene genetic chromosome analysis polymorphism genes dna region population patient human allele marker disease locus molecular chromosomes chain individual
Topic 25: species population plant infection water fish level host animal egg soil larvae parasite number concentration adult effect infected control year
Topic 26: strain infection antibiotic isolates bacteria bacterial resistance coli resistant isolated organism culture species tuberculosis positive gram aureus negative pathogen antimicrobial
Topic 27: patient level serum renal concentration plasma ml normal urinary control liver mg blood urine excretion values chronic significantly disease ng
Topic 28: patient imaging ct resonance brain lesion cerebral tomography mri magnetic scan diagnosis images contrast computed clinical artery examination carotid ultrasound
Topic 29: hormone level effect rat receptor estrogen day thyroid pituitary concentration gh growth lh secretion serum plasma treatment igf steroid progesterone
Topic 30: muscle exercise nerve degrees muscles activity temperature motor stimulation pain spinal cord control training effect skeletal injury fiber test force
Topic 31: virus infection hiv viral hepatitis infected immunodeficiency human type cell hcv viruses aid vaccine disease positive strain dna simplex influenza
Topic 32: diet weight acid food fat intake body dietary fed effect protein milk vitamin day level rat feeding energy concentration kg
Topic 33: infant pregnancy women fetal birth maternal sperm pregnant age mother neonatal gestation newborn day delivery week weight rate gestational pregnancies
Topic 34: insulin glucose diabetes cholesterol diabetic level plasma lipoprotein factor type lipid ldl control density patient blood concentration hdl effect serum
Topic 35: antibodies antibody antigen igg anti assay serum monoclonal patient test sera human protein positive elisa immunoglobulin mab immune igm cell
Topic 36: lung pulmonary respiratory patient airway asthma oxygen ventilation pressure effect anesthesia volume air min function alveolar gas breathing bronchial control
Topic 37: patient cell transplantation marrow bone transplant leukemia graft donor recipient acute survival lymphoma stem rejection disease csf blood liver allograft
Topic 38: skin eyes patient retinal laser eye visual corneal len ocular light wound cataract treatment glaucoma intraocular acuity burn surgery optic
Topic 39: gastric patient intestinal bile pancreatic pylori ulcer bowel mucosa disease duct mucosal gastrointestinal small acid colon secretion biliary intestine pancreatitis
Topic 40: effect platelet induced prostaglandin histamine release pge neutrophil allergic inflammatory acid inhibitor mast ige allergen reaction human cox cell inhibition
Topic 41: blood platelet cell iron red hemoglobin transfusion patient plasma count level erythrocytes malaria hb anemia normal erythrocyte rbc concentration lead
Topic 42: control group pd pc ii significantly cr cp mt pa pt ap lt level pb iii ac pe sp values
Topic 43: compound activity extract acid effect plant derivatives isolated inhibitor vitro drug potent agent active activities inhibition synthesis inhibitory tubulin chemical
Topic 44: dog cat horses animal canine equine horse clinical sign day foal mares breed examination disease feline lesion month samples affected
Topic 45: injuries flight accident injury driver space air exposure trauma car traffic military driving vehicle pilot pam death transport safety time
Topic 46: pleural effusion tea myasthenia tn trp gravis tyrosinase fluid tetracycline mg green malignant pericardial thymoma mesothelioma achr coffee caffeine melanoma
Topic 47: wnk aluminium swnt dal rj gloves nanotubes stream walled carbon pal handwriting wet aca toxicity questioned cohesin hyperkalemia gluten exhibit
Topic 48: isr collage fag vbt pnr tlr psi tripeptides opn homotypic tendencies production pannier context angles peaceful interact jakvf lenalidomide lrrk
Topic 49: culling antiandrogenic chr lncap culled ar aryl affect jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin
Topic 50: rassfa blu methylation jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb
Topic 51: ucht availability jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine
Topic 52: cbc internist gi jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb
Topic 53: hyperkalemia jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas
Topic 54: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 55: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 56: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 57: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 58: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 59: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 60: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 61: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 62: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 63: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 64: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 65: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 66: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 67: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 68: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 69: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 70: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 71: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 72: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 73: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 74: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 75: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 76: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 77: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 78: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 79: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 80: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 81: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 82: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 83: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 84: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 85: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 86: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 87: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 88: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 89: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 90: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 91: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 92: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 93: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 94: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 95: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 96: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 97: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 98: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 99: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 100: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 101: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 102: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 103: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 104: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 105: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 106: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 107: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 108: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 109: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 110: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 111: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 112: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 113: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 114: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 115: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 116: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 117: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 118: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 119: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 120: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 121: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 122: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 123: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 124: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 125: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 126: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 127: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 128: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 129: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 130: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 131: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 132: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 133: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 134: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 135: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 136: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 137: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 138: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 139: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 140: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 141: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 142: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 143: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 144: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 145: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 146: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 147: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 148: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 149: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 150: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 151: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 152: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 153: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 154: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 155: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 156: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 157: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 158: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 159: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 160: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 161: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 162: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 163: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 164: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 165: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 166: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 167: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 168: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 169: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 170: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 171: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 172: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 173: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 174: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 175: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 176: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 177: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 178: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 179: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 180: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 181: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 182: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 183: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 184: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 185: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 186: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 187: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 188: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 189: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 190: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 191: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 192: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 193: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 194: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 195: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 196: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 197: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 198: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 199: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 200: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 201: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 202: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 203: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 204: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 205: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 206: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 207: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 208: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 209: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 210: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 211: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 212: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 213: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 214: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 215: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 216: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 217: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 218: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 219: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 220: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 221: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 222: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 223: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 224: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 225: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 226: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 227: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 228: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 229: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 230: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 231: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 232: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 233: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 234: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 235: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 236: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 237: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 238: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 239: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 240: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 241: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 242: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 243: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 244: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 245: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 246: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 247: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 248: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 249: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 250: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 251: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 252: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 253: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 254: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 255: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 256: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 257: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 258: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 259: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 260: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 261: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 262: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 263: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 264: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 265: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 266: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 267: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 268: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 269: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 270: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 271: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 272: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 273: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 274: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 275: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 276: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 277: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 278: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 279: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 280: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 281: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 282: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 283: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 284: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 285: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 286: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 287: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 288: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 289: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 290: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 291: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 292: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 293: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 294: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 295: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 296: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 297: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 298: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 299: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 300: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 301: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 302: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 303: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 304: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 305: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 306: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 307: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 308: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 309: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 310: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 311: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 312: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 313: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 314: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 315: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 316: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 317: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 318: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 319: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 320: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 321: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 322: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 323: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 324: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 325: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 326: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 327: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 328: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 329: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 330: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 331: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 332: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 333: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 334: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 335: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 336: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 337: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 338: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 339: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 340: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 341: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 342: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 343: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 344: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 345: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 346: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 347: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 348: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 349: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 350: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 351: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 352: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 353: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 354: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 355: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 356: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 357: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 358: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 359: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 360: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 361: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 362: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 363: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 364: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 365: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 366: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 367: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 368: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 369: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 370: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 371: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 372: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 373: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 374: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 375: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 376: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 377: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 378: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 379: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 380: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 381: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 382: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 383: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 384: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 385: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 386: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 387: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 388: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 389: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 390: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 391: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 392: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 393: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 394: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 395: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 396: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 397: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 398: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 399: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 400: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 401: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 402: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 403: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 404: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 405: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 406: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 407: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 408: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 409: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 410: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 411: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 412: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 413: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 414: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 415: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 416: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 417: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 418: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 419: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 420: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 421: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 422: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 423: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 424: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 425: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 426: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 427: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 428: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 429: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 430: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 431: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 432: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 433: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 434: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 435: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 436: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 437: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 438: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 439: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 440: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 441: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 442: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 443: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 444: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 445: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 446: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 447: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 448: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 449: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 450: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 451: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 452: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 453: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 454: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 455: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 456: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 457: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 458: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 459: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 460: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 461: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 462: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 463: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 464: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 465: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 466: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 467: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 468: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 469: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 470: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 471: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 472: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 473: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 474: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 475: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 476: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 477: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 478: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 479: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 480: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 481: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 482: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 483: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 484: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 485: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 486: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 487: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 488: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 489: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 490: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 491: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 492: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 493: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 494: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 495: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 496: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 497: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 498: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 499: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 500: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 501: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 502: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 503: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 504: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 505: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 506: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 507: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 508: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 509: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 510: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 511: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 512: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 513: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 514: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 515: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 516: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 517: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 518: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 519: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 520: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 521: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 522: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 523: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 524: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 525: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 526: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 527: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 528: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 529: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 530: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 531: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 532: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 533: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 534: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 535: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 536: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 537: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 538: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 539: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 540: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 541: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 542: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 543: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 544: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 545: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 546: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 547: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 548: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 549: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 550: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 551: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 552: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 553: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 554: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 555: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 556: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 557: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 558: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 559: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 560: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 561: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 562: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 563: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 564: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 565: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 566: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 567: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 568: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 569: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 570: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 571: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 572: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 573: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 574: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 575: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 576: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 577: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 578: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 579: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 580: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 581: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 582: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 583: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 584: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 585: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 586: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 587: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 588: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 589: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 590: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 591: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 592: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 593: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 594: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 595: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 596: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 597: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 598: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 599: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 600: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 601: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 602: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 603: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 604: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 605: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 606: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 607: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 608: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 609: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 610: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 611: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 612: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 613: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 614: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 615: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 616: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 617: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 618: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 619: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 620: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 621: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 622: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 623: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 624: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 625: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 626: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 627: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 628: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 629: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 630: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 631: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 632: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 633: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 634: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 635: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 636: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 637: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 638: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 639: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 640: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 641: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 642: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 643: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 644: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 645: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 646: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 647: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 648: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 649: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 650: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 651: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 652: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 653: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 654: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 655: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 656: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 657: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 658: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 659: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 660: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 661: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 662: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 663: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 664: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 665: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 666: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 667: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 668: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 669: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 670: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 671: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 672: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 673: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 674: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 675: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 676: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 677: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 678: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 679: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 680: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 681: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 682: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 683: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 684: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 685: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 686: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 687: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 688: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 689: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 690: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 691: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 692: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 693: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 694: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 695: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 696: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 697: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 698: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 699: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 700: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 701: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 702: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 703: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 704: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 705: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 706: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 707: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 708: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 709: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 710: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 711: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 712: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 713: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 714: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 715: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 716: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 717: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 718: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 719: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 720: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 721: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 722: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 723: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 724: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 725: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 726: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 727: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 728: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 729: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 730: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 731: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 732: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 733: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 734: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 735: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 736: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 737: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 738: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 739: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 740: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 741: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 742: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 743: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 744: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 745: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 746: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 747: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 748: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 749: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 750: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 751: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 752: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 753: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 754: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 755: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 756: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 757: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 758: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 759: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 760: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 761: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 762: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 763: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 764: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 765: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 766: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 767: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 768: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 769: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 770: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 771: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 772: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 773: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 774: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 775: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 776: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 777: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 778: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 779: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 780: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 781: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 782: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 783: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 784: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 785: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 786: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 787: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 788: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 789: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 790: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 791: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 792: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 793: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 794: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 795: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 796: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 797: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 798: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 799: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 800: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 801: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 802: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 803: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 804: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 805: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 806: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 807: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 808: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 809: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 810: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 811: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 812: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 813: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 814: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 815: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 816: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 817: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 818: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 819: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 820: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 821: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 822: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 823: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 824: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 825: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 826: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 827: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 828: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 829: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 830: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 831: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 832: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 833: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 834: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 835: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 836: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 837: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 838: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 839: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 840: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 841: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 842: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 843: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 844: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 845: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 846: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 847: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 848: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 849: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 850: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 851: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 852: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 853: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 854: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 855: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 856: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 857: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 858: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 859: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 860: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 861: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 862: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 863: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 864: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 865: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 866: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 867: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 868: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 869: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 870: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 871: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 872: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 873: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 874: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 875: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 876: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 877: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 878: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 879: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 880: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 881: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 882: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 883: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 884: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 885: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 886: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 887: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 888: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 889: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 890: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 891: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 892: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 893: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 894: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 895: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 896: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 897: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 898: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 899: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 900: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 901: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 902: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 903: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 904: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 905: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 906: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 907: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 908: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 909: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 910: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 911: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 912: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 913: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 914: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 915: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 916: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 917: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 918: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 919: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 920: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 921: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 922: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 923: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 924: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 925: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 926: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 927: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 928: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 929: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 930: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 931: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 932: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 933: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 934: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 935: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 936: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 937: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 938: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 939: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 940: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 941: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 942: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 943: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 944: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 945: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 946: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 947: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 948: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 949: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 950: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 951: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 952: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 953: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 954: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 955: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 956: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 957: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 958: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 959: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 960: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 961: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 962: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 963: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 964: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 965: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 966: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 967: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 968: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 969: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 970: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 971: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 972: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 973: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 974: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 975: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 976: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 977: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 978: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 979: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 980: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 981: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 982: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 983: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 984: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 985: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 986: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 987: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 988: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 989: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 990: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 991: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 992: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 993: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 994: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 995: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 996: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 997: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 998: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 999: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Topic 1000: jakvf lenalidomide lrrk iptakalim abatacept palifermin sorafenib telavancin resilon trimalpha vkorc hemojuvelin uniprot jirovecii adper ramelteon oatpb glulisine fxtas rimonabant
Relevance words are: 
Topic 1: care health medical research cost physician program practice nursing hospital services information problem management nurses quality education medicine public student
Topic 2: age risk children women year smoking prevalence ci population factor health adolescent disorder mortality depression alcohol aged older confidence social
Topic 3: gene dna sequence genes rna protein sequences expression promoter region cdna mutant transcription plasmid mrna transcript encoding amino coli element
Topic 4: model measurement data system simulation algorithm parameter field analysis image error equation computer based prediction dynamic set time dimensional distribution
Topic 5: treatment patient therapy trial drug placebo mg dose efficacy randomized controlled day week regimen effect month blind adverse pain treated
Topic 6: patient surgery surgical complication postoperative operation catheter laparoscopic operative vein procedure stent abdominal aneurysm underwent graft year procedures resection bladder
Topic 7: cancer tumor carcinoma breast tumour patient malignant survival prostate metastases carcinomas metastatic lymph radiotherapy metastasis node chemotherapy stage colorectal squamous
Topic 8: cell growth expression lines fibroblast human endothelial tgf proliferation culture factor cultured mrna cells mmp differentiation line cultures vegf beta
Topic 9: cell il cd lymphocytes tnf ifn interleukin immune mice gamma macrophages alpha cytokine lymphocyte lp cytokines antigen necrosis nk interferon
Topic 10: disease syndrome patient diagnosis clinical disorder symptom manifestation year diseases lesion severe rare features chronic lupus sclerosis sign arthritis children
Topic 11: cell neuron electron microscopy axon layer fiber ultrastructural staining nuclei nucleus nerve section neuronal glial distribution ganglion epithelium bodies granules
Topic 12: binding structure residues interaction crystal conformation bond site nmr complexes ligand protein conformational reaction structural complex domain residue peptide chain
Topic 13: kinase protein phosphorylation activation signaling pathway cell receptor tyrosine apoptosis expression nf pkc domain kinases hsp signal kappab cyclin regulation
Topic 14: ca channel na calcium receptor microm current voltage cai camp intracellular cyclase cyclic membrane atpase release effect agonist dependent concentration
Topic 15: liquid water solution chromatography samples concentration ph determination degrees spectrometry polymer column detection organic gas extraction separation adsorption chromatographic phase
Topic 16: acid enzyme activity oxidative dehydrogenase glutathione cytochrome metabolism mitochondrial oxidation enzymes liver oxidase oxygen reductase radical superoxide antioxidant fatty lipid
Topic 17: task memory sleep visual hearing auditory stimulus stimuli eeg learning movement cognitive word speech cortex temporal performance spatial deficit motor
Topic 18: pressure blood flow hypertension arterial angiotensin hypertensive ischemia vascular renin min reperfusion rat infusion hg oxide mmhg nitric effect ace
Topic 19: bone fractures joint implant fracture hip teeth knee dental cartilage ligament tooth flap mineral femoral tendon spine mandibular bmd periodontal
Topic 20: protein gel purified kda binding fraction enzyme sulfate electrophoresis molecular acid polyacrylamide chromatography dodecyl purification activity membrane lectin glycoprotein alpha
Topic 21: rat mice kg animal dose day ethanol mg liver exposure effect administration doses injection induced radiation exposed irradiation toxicity treated
Topic 22: heart ventricular coronary myocardial cardiac left infarction artery valve atrial patient mitral echocardiography lv angina aortic fibrillation ecg myocardium pacing
Topic 23: receptor dopamine rat neuron brain opioid morphine ht antagonist da effect serotonin nucleus agonist dopaminergic striatum naloxone striatal kg hypothalamus
Topic 24: mutation genetic chromosome polymorphism gene allele chromosomes alleles genes loci genotype locus linkage deletion families chromosomal dna marker analysis variant
Topic 25: species plant larvae fish parasite egg soil tick parasites worm host insect population water river sea trout larval bird cruzi
Topic 26: strain infection antibiotic isolates bacteria bacterial aureus coli gram staphylococcus antimicrobial tuberculosis organism resistant resistance pneumoniae pathogen aeruginosa salmonella streptococcus
Topic 27: serum renal level plasma concentration patient ml urinary excretion dialysis urine creatinine clearance albumin ng pth hemodialysis pharmacokinetic glomerular parathyroid
Topic 28: imaging ct resonance tomography mri scan magnetic cerebral images computed mr brain lesion pet carotid intracranial patient ultrasound angiography cyst
Topic 29: hormone estrogen gh pituitary lh thyroid progesterone testosterone estradiol igf cortisol steroid androgen prolactin adrenal acth fsh hormones tsh prl
Topic 30: muscle exercise muscles nerve motor degrees spinal cord skeletal temperature training force emg pain leg fiber contraction stimulation walking athletes
Topic 31: virus hiv infection viral hepatitis immunodeficiency infected hcv viruses simplex influenza hpv vaccine hbv hsv herpes aid ebv vaccination cmv
Topic 32: diet intake fat dietary food fed milk weight vitamin feeding body cow nutritional leptin fatty energy acid supplementation nutrition zinc
Topic 33: pregnancy infant fetal birth maternal sperm pregnant women gestation mother neonatal newborn gestational pregnancies preterm fetuses prenatal uterine abortion delivery
Topic 34: insulin diabetes glucose cholesterol diabetic lipoprotein ldl hdl islet mellitus plasma lipid density apolipoprotein level glucagon atherosclerosis fasting apo plasminogen
Topic 35: antibodies antibody antigen igg monoclonal sera anti assay elisa igm iga mab immunoglobulin immunosorbent serum titer epitopes test autoantibodies immunization
Topic 36: lung pulmonary respiratory airway asthma ventilation anesthesia oxygen breathing alveolar bronchial expiratory air inhaled anaesthesia fev anesthetic copd propofol inhalation
Topic 37: transplantation marrow transplant leukemia recipient lymphoma graft donor rejection bone allograft myeloid stem hodgkin hematopoietic csa patient cell aml csf
Topic 38: eyes retinal eye corneal laser skin len ocular visual cataract glaucoma intraocular acuity burn wound lenses optic macular iop retina
Topic 39: gastric intestinal bile pylori ulcer bowel pancreatic mucosa mucosal duct biliary pancreatitis duodenal gastrointestinal intestine stomach colitis colon colonic helicobacter
Topic 40: prostaglandin histamine pge allergic mast platelet allergen ige neutrophil cox eosinophil paf indomethacin atopic arachidonic allergy cyclooxygenase thromboxane release inflammatory
Topic 41: platelet iron blood red hemoglobin transfusion malaria hb rbc erythrocytes anemia falciparum erythrocyte plasmodium ferritin count epo sickle erythropoietin transferrin
Topic 42: pd cp mt pc pt cr pe pa ac ep mc ss pb sa ap mp pp hc np sm
Topic 43: compound extract plant alkaloid activity derivatives flavonoid tubulin herbal quercetin leaves medicinal potent herb seed ic phenolic glycosides saponin fruit
Topic 44: dog horses cat equine horse foal canine mares ponies breed lameness thoroughbred equi feline animal veterinary stallion ehv owner racing
Topic 45: flight driver accident pam aircraft car injuries crew scp military traffic passenger tv road abi crashes ste driving crash helicopter
Topic 46: pleural effusion tea myasthenia gravis tyrosinase trp tn egcg thymoma tet tetracycline dox catechin coffee achr thymectomy pericardial mesothelioma minocycline
Topic 47: dal wnk rj swnt irving spev aluminium nanotubes pmoa handwriting gloves walled microfiltration sfi pneumovax cohesin fibulae pal hughes vbf
Topic 48: collage fag vbt isr pnr pannier tripeptides homotypic tlr psi peaceful tendencies opn angles context production interact lict caec drotaa
Topic 49: culling antiandrogenic culled chr lncap aryl ar affect lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic
Topic 50: blu rassfa methylation lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm
Topic 51: ucht availability lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei
Topic 52: cbc internist gi lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm
Topic 53: hyperkalemia lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate
Topic 54: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 55: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 56: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 57: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 58: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 59: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 60: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 61: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 62: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 63: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 64: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 65: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 66: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 67: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 68: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 69: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 70: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 71: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 72: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 73: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 74: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 75: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 76: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 77: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 78: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 79: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 80: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 81: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 82: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 83: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 84: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 85: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 86: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 87: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 88: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 89: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 90: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 91: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 92: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 93: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 94: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 95: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 96: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 97: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 98: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 99: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 100: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 101: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 102: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 103: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 104: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 105: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 106: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 107: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 108: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 109: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 110: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 111: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 112: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 113: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 114: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 115: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 116: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 117: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 118: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 119: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 120: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 121: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 122: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 123: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 124: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 125: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 126: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 127: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 128: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 129: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 130: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 131: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 132: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 133: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 134: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 135: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 136: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 137: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 138: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 139: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 140: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 141: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 142: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 143: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 144: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 145: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 146: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 147: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 148: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 149: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 150: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 151: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 152: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 153: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 154: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 155: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 156: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 157: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 158: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 159: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 160: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 161: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 162: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 163: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 164: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 165: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 166: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 167: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 168: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 169: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 170: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 171: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 172: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 173: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 174: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 175: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 176: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 177: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 178: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 179: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 180: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 181: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 182: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 183: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 184: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 185: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 186: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 187: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 188: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 189: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 190: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 191: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 192: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 193: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 194: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 195: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 196: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 197: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 198: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 199: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 200: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 201: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 202: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 203: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 204: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 205: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 206: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 207: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 208: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 209: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 210: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 211: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 212: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 213: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 214: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 215: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 216: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 217: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 218: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 219: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 220: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 221: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 222: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 223: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 224: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 225: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 226: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 227: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 228: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 229: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 230: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 231: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 232: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 233: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 234: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 235: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 236: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 237: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 238: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 239: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 240: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 241: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 242: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 243: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 244: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 245: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 246: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 247: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 248: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 249: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 250: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 251: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 252: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 253: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 254: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 255: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 256: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 257: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 258: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 259: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 260: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 261: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 262: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 263: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 264: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 265: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 266: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 267: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 268: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 269: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 270: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 271: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 272: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 273: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 274: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 275: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 276: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 277: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 278: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 279: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 280: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 281: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 282: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 283: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 284: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 285: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 286: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 287: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 288: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 289: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 290: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 291: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 292: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 293: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 294: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 295: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 296: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 297: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 298: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 299: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 300: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 301: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 302: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 303: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 304: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 305: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 306: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 307: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 308: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 309: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 310: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 311: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 312: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 313: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 314: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 315: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 316: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 317: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 318: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 319: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 320: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 321: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 322: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 323: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 324: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 325: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 326: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 327: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 328: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 329: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 330: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 331: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 332: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 333: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 334: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 335: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 336: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 337: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 338: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 339: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 340: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 341: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 342: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 343: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 344: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 345: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 346: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 347: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 348: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 349: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 350: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 351: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 352: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 353: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 354: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 355: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 356: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 357: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 358: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 359: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 360: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 361: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 362: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 363: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 364: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 365: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 366: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 367: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 368: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 369: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 370: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 371: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 372: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 373: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 374: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 375: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 376: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 377: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 378: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 379: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 380: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 381: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 382: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 383: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 384: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 385: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 386: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 387: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 388: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 389: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 390: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 391: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 392: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 393: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 394: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 395: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 396: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 397: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 398: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 399: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 400: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 401: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 402: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 403: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 404: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 405: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 406: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 407: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 408: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 409: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 410: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 411: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 412: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 413: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 414: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 415: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 416: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 417: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 418: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 419: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 420: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 421: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 422: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 423: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 424: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 425: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 426: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 427: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 428: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 429: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 430: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 431: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 432: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 433: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 434: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 435: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 436: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 437: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 438: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 439: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 440: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 441: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 442: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 443: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 444: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 445: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 446: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 447: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 448: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 449: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 450: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 451: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 452: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 453: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 454: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 455: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 456: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 457: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 458: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 459: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 460: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 461: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 462: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 463: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 464: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 465: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 466: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 467: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 468: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 469: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 470: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 471: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 472: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 473: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 474: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 475: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 476: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 477: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 478: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 479: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 480: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 481: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 482: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 483: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 484: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 485: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 486: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 487: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 488: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 489: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 490: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 491: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 492: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 493: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 494: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 495: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 496: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 497: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 498: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 499: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 500: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 501: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 502: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 503: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 504: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 505: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 506: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 507: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 508: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 509: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 510: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 511: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 512: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 513: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 514: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 515: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 516: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 517: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 518: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 519: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 520: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 521: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 522: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 523: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 524: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 525: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 526: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 527: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 528: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 529: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 530: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 531: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 532: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 533: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 534: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 535: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 536: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 537: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 538: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 539: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 540: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 541: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 542: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 543: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 544: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 545: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 546: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 547: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 548: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 549: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 550: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 551: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 552: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 553: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 554: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 555: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 556: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 557: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 558: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 559: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 560: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 561: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 562: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 563: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 564: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 565: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 566: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 567: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 568: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 569: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 570: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 571: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 572: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 573: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 574: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 575: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 576: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 577: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 578: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 579: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 580: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 581: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 582: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 583: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 584: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 585: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 586: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 587: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 588: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 589: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 590: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 591: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 592: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 593: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 594: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 595: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 596: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 597: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 598: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 599: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 600: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 601: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 602: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 603: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 604: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 605: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 606: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 607: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 608: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 609: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 610: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 611: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 612: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 613: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 614: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 615: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 616: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 617: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 618: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 619: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 620: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 621: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 622: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 623: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 624: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 625: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 626: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 627: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 628: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 629: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 630: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 631: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 632: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 633: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 634: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 635: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 636: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 637: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 638: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 639: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 640: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 641: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 642: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 643: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 644: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 645: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 646: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 647: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 648: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 649: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 650: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 651: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 652: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 653: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 654: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 655: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 656: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 657: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 658: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 659: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 660: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 661: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 662: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 663: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 664: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 665: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 666: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 667: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 668: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 669: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 670: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 671: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 672: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 673: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 674: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 675: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 676: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 677: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 678: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 679: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 680: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 681: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 682: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 683: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 684: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 685: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 686: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 687: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 688: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 689: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 690: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 691: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 692: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 693: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 694: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 695: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 696: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 697: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 698: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 699: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 700: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 701: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 702: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 703: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 704: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 705: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 706: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 707: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 708: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 709: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 710: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 711: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 712: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 713: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 714: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 715: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 716: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 717: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 718: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 719: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 720: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 721: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 722: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 723: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 724: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 725: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 726: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 727: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 728: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 729: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 730: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 731: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 732: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 733: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 734: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 735: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 736: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 737: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 738: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 739: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 740: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 741: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 742: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 743: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 744: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 745: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 746: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 747: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 748: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 749: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 750: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 751: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 752: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 753: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 754: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 755: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 756: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 757: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 758: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 759: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 760: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 761: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 762: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 763: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 764: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 765: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 766: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 767: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 768: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 769: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 770: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 771: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 772: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 773: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 774: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 775: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 776: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 777: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 778: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 779: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 780: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 781: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 782: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 783: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 784: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 785: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 786: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 787: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 788: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 789: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 790: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 791: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 792: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 793: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 794: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 795: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 796: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 797: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 798: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 799: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 800: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 801: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 802: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 803: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 804: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 805: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 806: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 807: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 808: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 809: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 810: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 811: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 812: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 813: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 814: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 815: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 816: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 817: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 818: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 819: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 820: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 821: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 822: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 823: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 824: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 825: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 826: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 827: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 828: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 829: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 830: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 831: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 832: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 833: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 834: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 835: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 836: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 837: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 838: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 839: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 840: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 841: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 842: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 843: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 844: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 845: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 846: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 847: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 848: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 849: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 850: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 851: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 852: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 853: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 854: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 855: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 856: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 857: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 858: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 859: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 860: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 861: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 862: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 863: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 864: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 865: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 866: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 867: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 868: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 869: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 870: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 871: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 872: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 873: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 874: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 875: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 876: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 877: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 878: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 879: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 880: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 881: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 882: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 883: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 884: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 885: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 886: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 887: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 888: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 889: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 890: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 891: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 892: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 893: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 894: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 895: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 896: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 897: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 898: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 899: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 900: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 901: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 902: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 903: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 904: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 905: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 906: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 907: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 908: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 909: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 910: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 911: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 912: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 913: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 914: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 915: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 916: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 917: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 918: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 919: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 920: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 921: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 922: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 923: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 924: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 925: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 926: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 927: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 928: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 929: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 930: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 931: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 932: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 933: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 934: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 935: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 936: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 937: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 938: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 939: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 940: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 941: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 942: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 943: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 944: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 945: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 946: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 947: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 948: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 949: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 950: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 951: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 952: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 953: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 954: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 955: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 956: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 957: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 958: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 959: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 960: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 961: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 962: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 963: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 964: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 965: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 966: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 967: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 968: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 969: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 970: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 971: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 972: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 973: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 974: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 975: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 976: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 977: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 978: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 979: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 980: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 981: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 982: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 983: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 984: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 985: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 986: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 987: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 988: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 989: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 990: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 991: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 992: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 993: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 994: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 995: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 996: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 997: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 998: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 999: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic 1000: lict caec drotaa cydab tigemonam aidb phaso gkd hfas ntv detubulated carminic foxmb hhrb tnfrsfb hemeselect spamm asei phenthoate heterokont
Topic Occurence Count:
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
Active topics:
[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 6, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 7, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 8, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 12, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 14, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 25, 24, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27]
Active topics in data:
[16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 15, 16, 16, 16, 16, 16, 17, 17, 17, 18, 18, 18, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 16, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 17, 16, 16, 16, 16, 16, 16, 16, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 16, 17, 17, 16, 16, 15, 17, 16, 16, 16, 16, 17, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 15, 16, 16, 16, 16, 16, 17, 16, 17, 17, 18, 18, 17, 18, 18, 18, 18, 18, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 16, 17, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 16, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 16, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 16, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 16, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 18, 18, 19, 18, 18, 19, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 20, 18, 18, 18, 18, 19, 19, 19, 19, 19, 18, 18, 18, 18, 18, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 18, 18, 18, 18, 19, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 19, 19, 19, 18, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 18, 18, 18, 18, 18, 18, 18, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 18, 18, 17, 17, 17, 17, 17, 17, 17, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 19, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 20, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 17, 18, 19, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 19, 18, 18, 18, 18, 19, 19, 18, 18, 18, 18, 19, 19, 19, 19, 19, 19, 20, 21, 20, 20, 20, 21, 20, 20, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 21, 20, 19, 19, 20, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 20, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 18, 19, 20, 19, 19, 19, 19, 20, 19, 20, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 20, 20, 20, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 20, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 18, 19, 19, 19, 19, 19, 20, 20, 19, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 19, 20, 20, 19, 19, 19, 19, 19, 20, 20, 19, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 21, 21, 20, 20, 21, 20, 20, 20, 20, 20, 21, 23, 21, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 20, 20, 20, 21, 22, 21, 22, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22, 21, 21, 21, 22, 21, 21, 21, 21, 23, 21, 21, 22, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 20, 20, 19, 20, 19, 20, 20, 21, 21, 20, 20, 20, 20, 20, 21, 20, 20, 20, 21, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 21, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 21, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 21, 21, 20, 20, 20, 20, 20, 20, 21, 20, 20, 21, 20, 20, 20, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 21, 20, 21, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 21, 21, 21, 21, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 19, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 19, 20, 20, 20, 20, 21, 20, 21, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 21, 20, 20, 20, 20, 21, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 21, 21, 20, 21, 20, 20, 20, 20, 21, 20, 20, 20, 20, 21, 20, 20, 21, 20, 20, 20, 20, 20, 21, 22, 21, 22, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 21, 22, 22, 23, 22, 22, 23, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 23, 22, 22, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 24, 23, 23, 23, 23, 24, 23, 24, 23, 23, 22, 22, 22, 23, 22, 22, 22, 22, 22, 21, 21, 21, 21, 21, 22, 21, 21, 22, 21, 23, 22, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 23, 21, 22, 21, 21, 22, 22, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 20, 21, 22, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 22, 23, 21, 21, 21, 21, 21, 21, 21, 22, 22, 21, 21, 22, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 22, 22, 23, 23, 24, 23, 23, 23, 23, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 24, 23, 22, 22, 22, 23, 22, 21, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 23, 22, 23, 23, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 22, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 22, 22, 21, 21, 21, 21, 21, 22, 22, 22, 21, 21, 21, 23, 21, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 22, 22, 21, 21, 21, 22, 21, 21, 21, 21, 21, 22, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 21, 22, 21, 23, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 23, 24, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 21, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 21, 22, 22, 22, 21, 22, 22, 23, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 21, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 21, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 21, 22, 22, 22, 22, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 21, 21, 21, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 21, 22, 21, 22, 23, 21, 22, 21, 21, 21, 21, 21, 22, 21, 21, 21, 21, 21, 21, 22, 21, 21, 22, 21, 21, 22, 21, 22, 21, 21, 21, 21, 21, 21, 22, 21, 22, 21, 21, 21, 21, 22, 21, 21, 21, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 22, 21, 22, 22, 22, 22, 21, 21, 21, 22, 22, 21, 21, 21, 21, 22, 23, 22, 21, 20, 21, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 21, 21, 22, 21, 21, 21, 21, 22, 22, 22, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22, 22, 23, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 22, 22, 22, 22, 22, 23, 23, 23, 24, 24, 23, 23, 23, 23, 23, 23, 24, 23, 23, 22, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 24, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 22, 23, 23, 23, 24, 24, 24, 24, 25, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 25, 25, 24, 25, 24, 24, 24, 24, 24, 24, 24, 24, 26, 26, 26, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 24, 24, 24, 24, 24, 24, 25, 25, 25, 25, 25, 25, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 26, 24, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 24, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 26, 25, 25, 26, 25, 25, 25, 25, 25, 26, 26, 26, 24, 25, 25, 25, 25, 25, 26, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 25, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 25, 25, 26, 25, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 25, 27, 26, 26, 26, 25, 27, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 28, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 27, 27, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 25, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 28, 28, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 28, 26, 27, 26, 26, 26, 27, 26, 26, 26, 26, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 28, 27, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 27, 27, 26, 27, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 28, 26, 27, 25, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 24, 24, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 24, 25, 25, 24, 25, 25, 25, 25, 25, 25, 24, 26, 25, 25, 25, 25, 26, 25, 25, 24, 25, 25, 26, 25, 25, 26, 25, 25, 25, 25, 25, 26, 26, 27, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 26, 26, 26, 26, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 24, 25, 24, 24, 24, 24, 26, 26, 25, 25, 25, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 26, 26, 26, 26, 26, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 25, 27, 26, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 24, 25, 25, 25, 25, 25, 26, 25, 25, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 25, 25, 26, 25, 25, 25, 24, 25, 25, 25, 25, 25, 26, 25, 25, 26, 25, 25, 25, 26, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26, 27, 28, 26, 26, 26, 26, 26, 27, 27, 27, 27, 27, 27, 28, 27, 28, 27, 27, 27, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 25, 26, 26, 27, 28, 26, 26, 26, 26, 26, 25, 26, 25, 26, 26, 26, 26, 26, 26, 27, 26, 25, 26, 26, 26, 26, 26, 26, 27, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 27, 26, 26, 26, 27, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 26, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 28, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 29, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 27, 27, 27, 27, 27, 27, 27, 28, 29, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 29, 28, 29, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 26, 28, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 28, 27, 27, 27, 29, 27, 27, 27, 27, 28, 28, 27, 27, 27, 26, 27, 27, 28, 27, 29, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 26, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 28, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 29, 29, 27, 27, 27, 28, 27, 27, 27, 27, 26, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 29, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 27, 27, 27, 28, 30, 27, 27, 27, 27, 27, 28, 27, 28, 27, 28, 28, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 31, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 31, 29, 29, 29, 29, 30, 29, 30, 29, 29, 29, 29, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 29, 29, 29, 29, 29, 29, 29, 30, 31, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 30, 29, 30, 30, 30, 30, 30, 30, 31, 30, 29, 30, 31, 31, 30, 30, 30, 31, 33, 32, 32, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 30, 30, 32, 31, 31, 31, 31, 33, 32, 31, 30, 30, 31, 31, 30, 30, 30, 30, 30, 31, 31, 31, 31, 31, 30, 30, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 30, 29, 29, 29, 29, 29, 29, 30, 29, 30, 29, 29, 30, 29, 29, 29, 30, 29, 29, 28, 28, 28, 28, 28, 28, 28, 27, 29, 28, 30, 30, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 31, 29, 28, 29, 29, 29, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 27, 27, 27, 28, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 28, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 28, 28, 27, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 26, 27, 27, 27, 27, 27, 27, 27, 27, 27, 29, 28, 28, 27, 27, 27, 27, 28, 28, 28, 28, 28, 27, 27, 28, 27, 27, 27, 27, 27, 28, 27, 27, 27, 27, 27, 27, 27, 28, 27, 27, 27, 26, 27, 27, 29, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 27, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 29, 30, 29, 29, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 30, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 29, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 30, 29, 28, 29, 30, 29, 30, 29, 29, 29, 30, 30, 29, 29, 29, 29, 29, 30, 30, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 30, 30, 29, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 29, 30, 30, 30, 31, 30, 30, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 28, 29, 29, 29, 29, 29, 29, 29, 30, 31, 29, 30, 29, 29, 29, 29, 29, 29, 28, 29, 30, 29, 30, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 30, 30, 30, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 28, 30, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 29, 29, 29, 30, 29, 29, 30, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 29, 28, 27, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 30, 30, 29, 29, 28, 28, 28, 28, 28, 28, 28, 30, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 30, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 27, 28, 28, 28, 29, 29, 28, 29, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 31, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 29, 28, 27, 28, 28, 28, 29, 29, 28, 28, 28, 29, 29, 29, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 27, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 28, 28, 28, 29, 28, 28, 28, 29, 29, 29, 29, 29, 28, 28, 27, 28, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 27, 29, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 30, 28, 28, 30, 28, 29, 29, 28, 29, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 28, 28, 28, 29, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 29, 29, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 30, 29, 28, 29, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 27, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 29, 29, 29, 29, 29, 29, 29, 30, 28, 29, 29, 29, 28, 28, 28, 28, 28, 29, 28, 29, 28, 29, 28, 28, 27, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 29, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 27, 28, 28, 28, 28, 28, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 28, 28, 29, 29, 29, 30, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 28, 28, 29, 28, 28, 28, 28, 29, 28, 28, 28, 28, 28, 28, 29, 28, 28, 30, 28, 28, 29, 29, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 29, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 28, 29, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 30, 29, 29, 28, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 30, 30, 29, 29, 29, 29, 31, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 28, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 30, 29, 28, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 31, 29, 28, 29, 29, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 28, 31, 28, 29, 29, 28, 29, 30, 30, 29, 29, 29, 29, 29, 29, 29, 28, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 30, 30, 30, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 30, 29, 30, 30, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 29, 29, 29, 30, 29, 29, 29, 29, 30, 29, 29, 29, 29, 29, 29, 28, 29, 29, 29, 29, 29, 30, 30, 30, 30, 30, 30, 30, 29, 31, 29, 30, 31, 31, 30, 30, 30, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 31, 31, 30, 31, 32, 30, 30, 31, 31, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 31, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 31, 30, 31, 30, 31, 30, 30, 30, 30, 30, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 31, 31, 32, 33, 34, 32, 32, 31, 33, 32, 32, 32, 32, 32, 34, 33, 32, 32, 32, 32, 33, 33, 33, 32, 33, 33, 32, 32, 32, 32, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 30, 31, 33, 33, 32, 32, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 31, 31, 30, 31, 31, 31, 31, 31, 33, 31, 31, 30, 30, 29, 30, 31, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 32, 32, 31, 31, 30, 30, 30, 30, 31, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 32, 32, 30, 30, 31, 30, 31, 30, 30, 30, 30, 30, 30, 31, 31, 30, 30, 29, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 31, 30, 30, 30, 30, 31, 30, 30, 31, 30, 30, 32, 30, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 32, 31, 32, 31, 31, 31, 33, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 32, 31, 32, 33, 33, 33, 33, 33, 33, 33, 32, 31, 31, 31, 31, 32, 31, 31, 32, 32, 32, 32, 33, 32, 32, 31, 32, 32, 33, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 33, 32, 32, 32, 32, 32, 32, 33, 33, 33, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 33, 32, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 33, 33, 32, 32, 33, 32, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 31, 32, 33, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 34, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 33, 32, 32, 32, 32, 33, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 31, 33, 31, 32, 33, 33, 34, 32, 32, 32, 32, 32, 32, 33, 33, 33, 34, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 35, 32, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 34, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 33, 32, 32, 33, 34, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 33, 32, 32, 34, 34, 33, 32, 31, 33, 32, 32, 32, 32, 32, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 34, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 33, 33, 33, 32, 34, 33, 33, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 32, 33, 32, 33, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 33, 32, 32, 33, 33, 32, 32, 32, 32, 33, 32, 32, 32, 32, 33, 33, 32, 33, 32, 32, 32, 32, 33, 33, 32, 33, 33, 34, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 31, 31, 31, 31, 31, 31, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 31, 31, 32, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 32, 32, 33, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 33, 34, 33, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 32, 32, 31, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 32, 32, 33, 33, 32, 32, 31, 32, 32, 33, 33, 33, 32, 32, 32, 32, 32, 32, 32, 33, 32, 32, 32, 32, 33, 33, 33, 32, 33, 32, 32, 32, 32, 32, 33, 33, 32, 32, 32, 34, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 32, 33, 33, 34, 33, 33, 33, 34, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 34, 34, 35, 35, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 37, 35, 35, 35, 34, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 34, 34, 34, 34, 34, 34, 35, 34, 33, 34, 33, 33, 34, 33, 33, 33, 33, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 34, 34, 33, 33, 33, 33, 34, 34, 34, 33, 33, 33, 33, 33, 34, 34, 33, 34, 33, 34, 35, 34, 35, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 33, 35, 34, 34, 35, 36, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 33, 34, 34, 33, 34, 34, 35, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 34, 34, 34, 34, 34, 34, 34, 33, 34, 35, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 35, 34, 35, 34, 34, 34, 34, 35, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 34, 34, 34, 35, 34, 34, 34, 35, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 35, 33, 34, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 33, 34, 35, 35, 35, 36, 36, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 33, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 35, 35, 34, 34, 34, 36, 34, 34, 34, 35, 34, 35, 34, 35, 35, 34, 35, 33, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 35, 35, 35, 34, 34, 34, 34, 34, 33, 34, 35, 35, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 35, 34, 34, 34, 34, 33, 34, 34, 34, 34, 34, 34, 34, 34, 33, 35, 34, 34, 33, 33, 34, 34, 34, 35, 34, 34, 35, 34, 34, 34, 34, 35, 35, 35, 35, 36, 36, 34, 34, 34, 34, 34, 34, 34, 34, 36, 36, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 35, 35, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 34, 35, 34, 34, 34, 34, 34, 34, 34, 34, 35, 34, 34, 36, 36, 36, 36, 35, 35, 35, 35, 35, 35, 36, 35, 36, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 36, 35, 35, 35, 36, 35, 36, 35, 36, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 35, 36, 37, 36, 36, 37, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 35, 37, 36, 37, 36, 36, 36, 36, 36, 35, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 37, 37, 38, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 37, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 38, 35, 36, 36, 35, 35, 35, 36, 35, 36, 36, 36, 38, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 36, 35, 35, 35, 36, 35, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 36, 38, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 35, 36, 35, 35, 36, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 36, 36, 35, 35, 35, 35, 34, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 36, 34, 35, 35, 34, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 34, 35, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 38, 35, 36, 36, 35, 36, 37, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 36, 36, 35, 36, 36, 35, 36, 35, 36, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 36, 36, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 34, 35, 35, 35, 35, 36, 36, 37, 37, 36, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 34, 35, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 37, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 35, 35, 37, 36, 34, 35, 35, 35, 35, 35, 35, 35, 36, 35, 36, 35, 35, 35, 35, 35, 35, 37, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 36, 35, 34, 35, 36, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 36, 35, 35, 35, 35, 35, 35, 36, 35, 35, 36, 35, 35, 36, 36, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 34, 35, 35, 36, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 34, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 36, 35, 35, 34, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 35, 35, 36, 36, 35, 35, 35, 36, 36, 36, 36, 36, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 35, 37, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 35, 37, 36, 35, 36, 37, 37, 37, 37, 38, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 35, 36, 36, 36, 36, 37, 36, 36, 36, 37, 37, 36, 36, 38, 36, 36, 37, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 37, 36, 38, 36, 36, 36, 36, 37, 38, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 36, 37, 36, 36, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 38, 36, 38, 37, 37, 36, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 39, 37, 38, 37, 37, 37, 37, 37, 37, 38, 38, 40, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 38, 39, 36, 37, 37, 37, 37, 38, 37, 39, 37, 37, 37, 37, 36, 37, 37, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 37, 38, 38, 38, 39, 37, 38, 37, 38, 38, 38, 38, 38, 39, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 37, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 40, 39, 38, 39, 39, 38, 38, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 40, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 40, 39, 39, 38, 38, 38, 38, 39, 39, 39, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 36, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 39, 38, 38, 38, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 38, 36, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 38, 38, 37, 37, 36, 37, 38, 36, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 38, 38, 38, 37, 37, 37, 37, 37, 37, 39, 37, 37, 39, 38, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 38, 37, 38, 38, 37, 38, 38, 38, 37, 37, 37, 37, 38, 37, 37, 37, 38, 38, 38, 37, 37, 37, 38, 37, 39, 41, 37, 37, 36, 36, 36, 36, 36, 36, 36, 36, 36, 36, 37, 37, 37, 37, 37, 36, 36, 37, 37, 36, 37, 37, 37, 38, 37, 38, 37, 37, 38, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 38, 38, 37, 37, 36, 36, 36, 36, 36, 37, 36, 36, 37, 36, 36, 36, 37, 36, 36, 36, 36, 36, 36, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 39, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 38, 37, 38, 38, 38, 37, 37, 37, 38, 37, 38, 38, 38, 38, 39, 37, 37, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 36, 37, 38, 37, 37, 37, 37, 39, 37, 38, 37, 38, 37, 38, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 38, 37, 37, 38, 37, 38, 38, 38, 38, 37, 37, 37, 37, 37, 37, 37, 37, 39, 38, 37, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 37, 37, 38, 36, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 36, 37, 38, 38, 38, 37, 37, 37, 38, 38, 37, 37, 37, 38, 38, 38, 37, 38, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 36, 36, 37, 37, 37, 37, 38, 37, 38, 37, 38, 37, 37, 37, 37, 37, 37, 38, 38, 37, 37, 38, 37, 37, 38, 37, 37, 37, 37, 37, 38, 38, 38, 37, 37, 37, 36, 37, 37, 37, 37, 38, 37, 39, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 38, 39, 37, 37, 38, 37, 37, 37, 37, 38, 38, 37, 37, 37, 38, 39, 39, 38, 39, 39, 39, 39, 38, 37, 37, 38, 38, 37, 36, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 38, 38, 38, 38, 37, 37, 37, 38, 37, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 36, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 39, 38, 37, 37, 39, 38, 38, 37, 37, 38, 38, 37, 38, 38, 38, 38, 38, 38, 37, 37, 38, 38, 38, 38, 39, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 38, 38, 37, 38, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 37, 38, 37, 37, 37, 38, 37, 37, 37, 38, 37, 38, 38, 37, 37, 37, 38, 37, 37, 37, 38, 38, 37, 37, 37, 38, 38, 37, 37, 37, 37, 37, 38, 37, 37, 37, 37, 37, 37, 37, 39, 37, 37, 39, 37, 38, 37, 37, 37, 37, 38, 37, 37, 38, 39, 38, 37, 38, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 37, 38, 38, 38, 39, 38, 38, 39, 39, 38, 38, 38, 40, 38, 38, 38, 38, 39, 38, 38, 38, 39, 39, 40, 39, 39, 39, 39, 39, 38, 39, 40, 39, 39, 39, 39, 40, 40, 39, 40, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 41, 38, 39, 38, 38, 39, 38, 39, 39, 39, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 40, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 39, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 39, 40, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 37, 39, 38, 38, 38, 38, 37, 39, 38, 38, 38, 39, 39, 38, 39, 39, 38, 39, 38, 37, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 39, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 40, 38, 38, 39, 38, 38, 38, 38, 39, 40, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 40, 40, 39, 39, 39, 40, 40, 39, 40, 39, 41, 39, 40, 38, 38, 39, 38, 39, 40, 39, 38, 39, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 39, 40, 40, 39, 39, 39, 39, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 37, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 40, 39, 39, 39, 39, 39, 37, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 39, 39, 39, 39, 39, 39, 39, 39, 40, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 40, 38, 38, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 38, 38, 38, 37, 37, 39, 39, 38, 39, 38, 39, 38, 38, 38, 39, 37, 38, 38, 39, 38, 38, 38, 38, 37, 39, 38, 38, 38, 38, 40, 39, 38, 39, 38, 39, 39, 38, 38, 38, 38, 38, 39, 38, 37, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 39, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 38, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 38, 38, 38, 39, 40, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 39, 38, 39, 38, 38, 38, 40, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 37, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 40, 38, 38, 38, 38, 38, 39, 38, 40, 38, 39, 41, 39, 38, 38, 38, 37, 39, 39, 39, 38, 38, 39, 37, 38, 38, 39, 38, 39, 38, 39, 38, 39, 38, 40, 41, 38, 38, 38, 38, 39, 39, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 38, 38, 37, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 39, 39, 38, 38, 39, 39, 38, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 38, 38, 39, 39, 38, 38, 38, 39, 38, 38, 37, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 39, 39, 38, 37, 38, 38, 38, 39, 38, 38, 37, 38, 38, 39, 39, 40, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 38, 39, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 39, 39, 38, 38, 38, 39, 38, 39, 38, 40, 38, 38, 40, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 38, 37, 39, 38, 38, 38, 40, 38, 38, 39, 39, 39, 38, 38, 39, 38, 37, 38, 38, 38, 38, 38, 39, 38, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 38, 38, 38, 38, 38, 38, 38, 39, 39, 37, 38, 38, 39, 38, 39, 38, 38, 38, 39, 38, 38, 38, 38, 39, 38, 39, 38, 38, 38, 38, 38, 37, 38, 38, 38, 38, 38, 39, 38, 38, 38, 38, 38, 38, 38, 38, 38, 39, 38, 38, 37, 39, 39, 38, 38, 39, 39, 38, 38, 38, 38, 39, 39, 38, 38, 38, 39, 39, 38, 39, 39, 39, 39, 42, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 40, 39, 40, 39, 38, 39, 40, 39, 39, 39, 39, 39, 39, 40, 39, 38, 39, 39, 39, 39, 41, 40, 39, 41, 41, 41, 40, 41, 40, 40, 41, 41, 41, 42, 41, 40, 40, 41, 42, 41, 42, 41, 41, 41, 40, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 39, 41, 40, 40, 40, 40, 40, 40, 40, 39, 39, 39, 39, 40, 39, 39, 39, 40, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 38, 39, 40, 39, 39, 39, 40, 40, 41, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 39, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 40, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 41, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 40, 40, 41, 39, 40, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 40, 39, 39, 40, 39, 39, 40, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 40, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 41, 39, 39, 39, 39, 39, 39, 40, 39, 39, 39, 39, 40, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 39, 40, 40, 40, 39, 39, 39, 40, 40, 39, 39, 39, 39, 40, 39, 41, 39, 39, 39, 39, 40, 40, 39, 39, 39, 40, 39, 38, 39, 39, 39, 39, 39, 39, 39, 41, 39, 39, 39, 40, 41, 40, 41, 40, 40, 40, 40, 40, 42, 40, 42, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 39, 42, 40, 41, 39, 39, 40, 39, 39, 39, 39, 39, 39, 40, 40, 40, 39, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 39, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 41, 41, 41, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 41, 41, 40, 40, 41, 40, 40, 40, 41, 39, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 39, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 41, 40, 40, 41, 42, 40, 40, 41, 42, 43, 41, 43, 42, 44, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 40, 40, 40, 40, 41, 40, 40, 41, 41, 40, 40, 41, 40, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 43, 41, 40, 41, 43, 41, 42, 42, 41, 42, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 40, 40, 40, 40, 41, 39, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 42, 39, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 39, 40, 40, 41, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 41, 42, 40, 41, 40, 41, 40, 40, 39, 41, 41, 41, 42, 41, 40, 40, 40, 40, 41, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 42, 41, 42, 41, 40, 40, 40, 41, 40, 39, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 41, 40, 40, 40, 41, 41, 40, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 41, 40, 40, 41, 40, 41, 41, 41, 42, 42, 41, 41, 41, 42, 42, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 42, 41, 40, 41, 40, 40, 40, 40, 41, 40, 40, 41, 40, 39, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 41, 40, 41, 40, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 40, 39, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 42, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 41, 40, 40, 41, 41, 42, 41, 41, 41, 41, 40, 41, 41, 40, 40, 41, 41, 42, 42, 41, 42, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 40, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 43, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 39, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 40, 40, 39, 41, 40, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 39, 40, 40, 41, 41, 41, 40, 40, 41, 40, 41, 40, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 41, 41, 40, 40, 41, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 42, 41, 40, 39, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 39, 40, 39, 40, 40, 41, 40, 40, 40, 41, 41, 41, 40, 40, 41, 41, 41, 41, 40, 40, 40, 41, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 42, 41, 40, 40, 40, 40, 41, 40, 40, 40, 41, 41, 41, 40, 40, 40, 41, 41, 40, 40, 41, 40, 40, 40, 41, 40, 41, 41, 40, 40, 40, 40, 41, 41, 41, 41, 40, 40, 39, 40, 41, 40, 40, 40, 40, 41, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 42, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 42, 41, 41, 41, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 39, 41, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 41, 39, 40, 40, 40, 40, 40, 40, 39, 39, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 43, 41, 41, 41, 41, 41, 40, 40, 42, 40, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 40, 41, 41, 42, 41, 41, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 41, 42, 41, 41, 41, 41, 41, 43, 41, 42, 41, 41, 42, 41, 41, 42, 42, 41, 41, 42, 41, 42, 45, 44, 44, 43, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 40, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 41, 42, 41, 41, 42, 43, 41, 41, 41, 41, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 41, 40, 41, 42, 42, 42, 41, 41, 41, 41, 41, 42, 42, 42, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 42, 42, 41, 41, 42, 43, 43, 43, 41, 42, 41, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 40, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 42, 41, 41, 42, 41, 41, 43, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 42, 41, 40, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 42, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 43, 42, 41, 41, 41, 41, 41, 42, 40, 41, 41, 41, 41, 41, 42, 42, 42, 42, 42, 43, 42, 41, 41, 42, 42, 42, 41, 41, 41, 41, 43, 41, 41, 41, 42, 42, 42, 43, 42, 42, 43, 42, 41, 41, 41, 43, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 40, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 42, 43, 41, 42, 40, 41, 41, 41, 42, 40, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 41, 41, 40, 41, 42, 42, 42, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 43, 42, 41, 42, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 41, 41, 42, 42, 42, 42, 41, 41, 42, 43, 41, 41, 42, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 42, 42, 41, 42, 42, 42, 42, 42, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 42, 40, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 43, 42, 44, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 43, 41, 41, 42, 40, 41, 41, 41, 41, 40, 41, 42, 41, 42, 40, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 40, 41, 41, 41, 42, 42, 41, 41, 41, 42, 42, 41, 41, 41, 40, 41, 41, 41, 40, 41, 40, 42, 41, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 42, 42, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 41, 39, 40, 40, 40, 41, 40, 41, 41, 41, 41, 41, 41, 42, 41, 41, 40, 40, 40, 41, 40, 39, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 42, 40, 40, 40, 40, 41, 40, 40, 40, 40, 41, 40, 40, 40, 41, 40, 41, 40, 40, 40, 42, 40, 40, 40, 40, 41, 42, 41, 40, 40, 40, 40, 40, 42, 41, 42, 40, 41, 40, 39, 40, 40, 40, 39, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 41, 40, 40, 41, 40, 40, 40, 39, 41, 40, 40, 39, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 42, 41, 40, 40, 41, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 41, 41, 41, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 41, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 42, 41, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 39, 40, 40, 39, 40, 40, 41, 40, 40, 41, 40, 40, 40, 39, 40, 41, 41, 40, 40, 40, 40, 40, 41, 40, 40, 40, 40, 40, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 40, 41, 41, 42, 44, 43, 43, 42, 41, 41, 41, 41, 41, 41, 40, 40, 41, 40, 41, 41, 41, 40, 40, 40, 40, 40, 40, 40, 39, 41, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 40, 41, 40, 41, 40, 40, 40, 40, 41, 41, 40, 40, 40, 40, 41, 41, 41, 40, 40, 40, 40, 40, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 43, 41, 42, 41, 41, 41, 42, 41, 42, 42, 41, 41, 41, 42, 42, 42, 42, 42, 40, 41, 41, 41, 41, 42, 42, 42, 42, 42, 40, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 42, 42, 42, 41, 42, 42, 41, 41, 42, 42, 42, 42, 41, 43, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 44, 42, 41, 41, 41, 41, 41, 41, 42, 42, 41, 41, 42, 41, 42, 41, 41, 41, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 41, 42, 42, 41, 41, 40, 41, 41, 42, 41, 42, 43, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 41, 42, 44, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 41, 41, 41, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 42, 41, 41, 41, 42, 41, 41, 42, 42, 42, 41, 41, 42, 41, 41, 41, 41, 42, 41, 42, 41, 41, 40, 41, 42, 41, 41, 41, 43, 43, 43, 42, 41, 41, 42, 41, 41, 41, 42, 40, 42, 40, 41, 41, 41, 42, 42, 41, 41, 41, 41, 43, 43, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 42, 41, 41, 41, 42, 41, 41, 42, 41, 42, 42, 41, 41, 41, 42, 41, 42, 41, 42, 42, 43, 41, 41, 42, 41, 41, 42, 42, 42, 42, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 44, 42, 44, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 43, 43, 42, 43, 43, 42, 43, 43, 43, 42, 42, 43, 42, 43, 43, 42, 42, 42, 42, 44, 42, 42, 42, 42, 42, 42, 43, 43, 43, 44, 44, 44, 43, 43, 44, 45, 43, 42, 43, 43, 43, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 44, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 43, 42, 44, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 44, 43, 44, 43, 43, 44, 43, 44, 43, 44, 43, 43, 43, 43, 44, 43, 43, 43, 43, 44, 43, 43, 44, 44, 44, 43, 43, 43, 43, 42, 43, 44, 43, 44, 45, 43, 43, 44, 42, 43, 43, 43, 43, 42, 44, 44, 43, 43, 43, 44, 43, 43, 43, 43, 44, 43, 43, 43, 44, 44, 43, 42, 43, 42, 42, 42, 44, 43, 43, 43, 44, 42, 42, 42, 42, 41, 44, 42, 44, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 43, 43, 43, 42, 42, 42, 42, 43, 43, 44, 44, 43, 43, 45, 43, 43, 43, 43, 44, 43, 43, 43, 43, 44, 45, 44, 43, 43, 43, 43, 43, 43, 43, 44, 43, 44, 43, 43, 43, 43, 43, 43, 44, 44, 43, 43, 42, 43, 43, 43, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 44, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 44, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 43, 43, 44, 43, 43, 43, 43, 43, 44, 43, 44, 43, 45, 43, 43, 43, 44, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 43, 43, 42, 42, 41, 42, 42, 43, 42, 43, 42, 43, 43, 42, 42, 42, 42, 42, 42, 44, 42, 42, 42, 42, 42, 44, 42, 43, 42, 42, 42, 42, 43, 43, 43, 42, 42, 43, 43, 42, 43, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 41, 43, 43, 42, 42, 43, 42, 42, 42, 43, 42, 42, 43, 42, 42, 42, 42, 44, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 45, 42, 43, 42, 42, 42, 42, 41, 42, 42, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 43, 43, 42, 42, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 44, 43, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 42, 42, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 41, 42, 42, 43, 42, 43, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 43, 42, 42, 42, 43, 41, 42, 42, 42, 43, 43, 42, 42, 42, 43, 43, 42, 42, 43, 43, 45, 44, 43, 43, 43, 44, 42, 42, 42, 42, 43, 44, 42, 43, 42, 43, 42, 42, 42, 43, 42, 42, 42, 43, 43, 42, 43, 42, 42, 42, 43, 43, 43, 43, 44, 43, 42, 43, 42, 43, 43, 43, 43, 43, 43, 42, 43, 41, 42, 42, 42, 42, 42, 42, 42, 42, 41, 43, 42, 42, 42, 42, 42, 42, 43, 42, 42, 44, 42, 43, 42, 42, 42, 42, 42, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 41, 43, 42, 42, 42, 42, 42, 43, 44, 42, 41, 42, 42, 42, 42, 42, 43, 43, 43, 43, 42, 42, 41, 42, 42, 41, 42, 41, 42, 40, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 43, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 42, 41, 42, 41, 42, 42, 41, 41, 41, 41, 42, 42, 41, 41, 41, 41, 41, 40, 41, 41, 41, 42, 43, 42, 41, 42, 42, 40, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 40, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 44, 42, 41, 42, 42, 41, 41, 42, 41, 41, 41, 43, 41, 41, 42, 41, 41, 42, 42, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 43, 41, 43, 41, 41, 41, 41, 42, 41, 42, 42, 42, 42, 43, 43, 43, 42, 42, 42, 43, 42, 42, 42, 42, 42, 42, 42, 44, 42, 41, 43, 42, 41, 42, 42, 42, 42, 42, 42, 42, 41, 42, 42, 42, 42, 42, 42, 42, 42, 42, 42, 41, 43, 43, 43, 43, 43, 42, 42, 42, 42, 45, 43, 42, 41, 42, 42, 43, 43, 43, 42, 42, 42, 43, 42, 42, 42, 43, 43, 45, 42, 42, 44, 42, 42, 42, 42, 43, 42, 43, 42, 41, 41, 41, 41, 41, 42, 42, 42, 42, 43, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 42, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 42, 41, 41, 41, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 41, 41, 43, 41, 41, 41, 41, 42, 41, 42, 42, 42, 42, 42, 42, 42, 43, 43, 42, 42, 42, 42, 42, 43, 45, 43, 42, 42, 42, 43, 41, 42, 42, 42, 42, 42, 42, 43, 42, 42, 43, 43, 42, 43, 42, 41, 43, 42, 42, 42, 42, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 44, 42, 42, 44, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 44, 44, 45, 45, 44, 44, 44, 43, 43, 44, 43, 44, 43, 43, 42, 43, 44, 45, 44, 44, 44, 44, 43, 44, 44, 43, 43, 42, 44, 43, 44, 43, 43, 44, 43, 44, 44, 43, 43, 43, 44, 45, 44, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 44, 43, 43, 43, 44, 43, 43, 43, 44, 43, 43, 43, 44, 43, 43, 43, 43, 43, 44, 42, 44, 44, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 43, 43, 43, 44, 43, 43, 43, 43, 43, 43, 42, 43, 43, 43, 43, 43, 45, 43, 43, 43, 43, 43, 45, 47, 45, 44, 44, 44, 44, 44, 43, 45, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 43, 43, 43, 43, 43, 43, 44, 43, 45, 43, 44, 44, 43, 43, 43, 43, 44, 43, 44, 44, 44, 45, 44, 46, 44, 44, 44, 44, 43, 43, 42, 45, 44, 44, 43, 43, 44, 43, 44, 44, 44, 44, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 44, 44, 43, 44, 43, 44, 44, 44, 45, 45, 44, 44, 44, 44, 45, 45, 44, 44, 44, 44, 43, 44, 44, 44, 44, 44, 44, 44, 44, 45, 45, 45, 44, 44, 44, 45, 45, 44, 44, 45, 44, 44, 45, 44, 44, 44, 44, 44, 44, 45, 45, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 45, 44, 44, 44, 44, 44, 46, 44, 45, 44, 44, 46, 45, 43, 45, 44, 44, 44, 44, 44, 44, 44, 44, 44, 44, 45, 44, 44, 45, 44, 44, 45, 45, 44, 44, 44, 44, 44, 44, 45, 45, 45, 44, 45, 46, 45, 45, 45, 45, 45, 45, 46, 45, 46, 46, 45, 46, 45, 45, 46, 45, 46, 46, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 44, 45, 45, 45, 46, 46, 44, 45, 45, 44, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 46, 45, 46, 46, 45, 45, 45, 45, 45, 46, 45, 46, 45, 46, 45, 45, 46, 45, 44, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 46, 45, 45, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 47, 45, 45, 45, 46, 45, 45, 46, 45, 45, 46, 45, 45, 46, 45, 45, 46, 45, 46, 46, 45, 46, 46, 46, 46, 45, 46, 46, 45, 46, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 47, 48, 47, 47, 47, 47, 47, 47, 48, 48, 48, 48, 48, 48, 48, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 49, 48, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 47, 47, 47, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 45, 44, 45, 46, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 46, 46, 45, 46, 46, 46, 47, 46, 45, 45, 45, 46, 48, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 47, 46, 46, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 47, 46, 45, 45, 45, 45, 46, 45, 44, 46, 45, 47, 45, 46, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 46, 45, 45, 45, 46, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 47, 46, 45, 45, 47, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 46, 46, 46, 46, 47, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 46, 46, 46, 47, 46, 47, 47, 45, 46, 46, 46, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 47, 47, 47, 47, 47, 46, 46, 47, 47, 48, 47, 46, 46, 47, 46, 46, 45, 46, 44, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 45, 46, 47, 48, 46, 45, 46, 47, 46, 47, 46, 45, 45, 45, 45, 45, 45, 45, 45, 47, 46, 45, 46, 46, 45, 45, 46, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 44, 46, 46, 46, 45, 45, 46, 44, 45, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 46, 46, 45, 45, 46, 47, 46, 45, 45, 45, 46, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 46, 46, 45, 45, 46, 45, 46, 45, 46, 45, 45, 46, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 47, 46, 46, 47, 46, 46, 45, 45, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 46, 46, 47, 47, 47, 46, 48, 46, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 47, 46, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 47, 45, 46, 45, 45, 45, 45, 45, 45, 44, 46, 45, 46, 46, 46, 46, 45, 44, 45, 45, 45, 45, 45, 45, 45, 44, 44, 45, 46, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 44, 45, 44, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 47, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 46, 45, 46, 46, 46, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 47, 47, 44, 46, 45, 46, 45, 45, 45, 45, 45, 45, 46, 47, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 47, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 46, 45, 46, 45, 46, 45, 46, 46, 45, 46, 45, 45, 45, 46, 46, 46, 45, 46, 46, 45, 46, 45, 45, 47, 45, 44, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 46, 46, 45, 45, 45, 45, 46, 46, 45, 46, 45, 45, 47, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 48, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 48, 45, 46, 46, 46, 45, 47, 46, 46, 45, 45, 46, 47, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 47, 46, 46, 45, 46, 45, 45, 45, 44, 45, 46, 45, 45, 45, 46, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 47, 45, 45, 46, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 44, 46, 45, 45, 47, 45, 48, 46, 46, 45, 45, 45, 45, 46, 46, 46, 46, 46, 45, 46, 46, 45, 45, 46, 47, 45, 46, 46, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 46, 46, 46, 45, 46, 45, 46, 46, 46, 45, 45, 46, 45, 46, 45, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 46, 46, 45, 45, 45, 45, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 47, 45, 47, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 48, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 47, 45, 45, 46, 45, 47, 45, 46, 46, 45, 46, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 44, 45, 45, 44, 45, 45, 45, 45, 45, 45, 45, 47, 46, 45, 44, 46, 44, 45, 45, 46, 45, 45, 45, 46, 45, 45, 45, 45, 45, 44, 45, 45, 46, 45, 45, 45, 46, 45, 45, 46, 46, 46, 45, 46, 46, 46, 47, 47, 49, 47, 47, 46, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 47, 46, 46, 46, 46, 46, 45, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 47, 47, 46, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 47, 47, 47, 47, 47, 46, 47, 48, 48, 48, 47, 47, 47, 46, 46, 46, 47, 46, 46, 47, 46, 47, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 46, 45, 45, 45, 45, 46, 46, 45, 45, 45, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 47, 45, 45, 46, 45, 44, 45, 45, 45, 45, 45, 46, 45, 45, 45, 46, 46, 45, 45, 46, 44, 45, 46, 45, 45, 46, 45, 45, 47, 46, 46, 46, 48, 46, 46, 48, 46, 46, 46, 46, 46, 47, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 46, 47, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 46, 44, 45, 45, 45, 45, 45, 45, 45, 45, 45, 44, 44, 46, 45, 45, 45, 45, 45, 44, 44, 45, 45, 46, 45, 48, 47, 45, 45, 45, 45, 44, 45, 46, 46, 46, 46, 46, 45, 45, 45, 45, 46, 45, 46, 45, 45, 46, 46, 47, 48, 48, 46, 46, 46, 47, 46, 46, 47, 46, 46, 45, 45, 45, 45, 45, 45, 45, 45, 45, 47, 46, 45, 45, 46, 46, 45, 46, 45, 45, 45, 45, 45, 45, 48, 45, 46, 46, 45, 45, 45, 46, 46, 45, 45, 45, 45, 47, 45, 47, 45, 46, 45, 45, 45, 46, 44, 46, 44, 45, 45, 45, 46, 45, 45, 45, 47, 46, 45, 45, 45, 45, 45, 46, 45, 45, 46, 46, 46, 46, 46, 47, 46, 46, 47, 47, 46, 46, 46, 47, 47, 46, 46, 46, 46, 46, 46, 46, 45, 45, 45, 45, 45, 45, 45, 46, 45, 45, 45, 45, 44, 46, 45, 45, 45, 45, 45, 46, 45, 46, 45, 45, 45, 45, 46, 45, 45, 44, 45, 45, 45, 46, 45, 45, 45, 45, 45, 46, 45, 46, 46, 45, 45, 45, 45, 45, 46, 45, 45, 46, 45, 45, 45, 45, 45, 45, 45, 45, 47, 45, 45, 45, 45, 46, 45, 45, 45, 45, 45, 45, 46, 47, 46, 46, 45, 46, 45, 46, 45, 45, 45, 45, 46, 46, 46, 45, 45, 45, 45, 45, 45, 46, 46, 47, 47, 47, 47, 48, 47, 48, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 47, 46, 46, 46, 48, 48, 47, 47, 46, 46, 47, 46, 46, 46, 46, 45, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 47, 47, 46, 45, 45, 47, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 45, 45, 46, 46, 46, 46, 46, 47, 47, 47, 47, 48, 47, 46, 46, 48, 47, 47, 47, 46, 46, 46, 48, 47, 48, 48, 46, 46, 48, 46, 47, 46, 47, 46, 46, 46, 48, 45, 46, 46, 48, 47, 47, 48, 47, 46, 47, 46, 46, 46, 46, 46, 46, 47, 46, 47, 46, 47, 47, 46, 47, 46, 47, 46, 46, 46, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 47, 46, 46, 46, 47, 48, 46, 47, 46, 46, 46, 46, 47, 47, 47, 46, 48, 46, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 47, 46, 47, 47, 47, 47, 47, 46, 46, 46, 46, 46, 47, 46, 46, 46, 46, 47, 46, 47, 46, 47, 46, 46, 46, 46, 47, 47, 46, 46, 47, 46, 46, 47, 46, 46, 46, 46, 46, 46, 46, 47, 47, 49, 47, 47, 49, 48, 47, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 47, 47, 48, 48, 48, 48, 47, 47, 47, 46, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 49, 48, 48, 48, 48, 49, 49, 47, 47, 47, 47, 47, 48, 48, 48, 47, 47, 47, 48, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 48, 47, 49, 48, 48, 49, 48, 47, 48, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 47, 49, 48, 49, 48, 47, 48, 48, 49, 48, 48, 48, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 48, 48, 48, 47, 48, 46, 47, 47, 47, 47, 47, 48, 46, 47, 48, 47, 47, 48, 47, 48, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 48, 47, 47, 48, 48, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 49, 47, 47, 47, 48, 47, 47, 47, 46, 47, 47, 47, 47, 48, 47, 47, 47, 49, 48, 48, 47, 47, 47, 47, 49, 48, 48, 48, 48, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 49, 48, 48, 47, 47, 47, 47, 48, 47, 48, 47, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 48, 49, 48, 48, 48, 47, 47, 47, 47, 47, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 47, 47, 48, 48, 47, 47, 47, 49, 48, 47, 48, 47, 47, 48, 47, 47, 47, 47, 47, 46, 48, 49, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 48, 47, 47, 46, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 47, 47, 46, 47, 48, 49, 46, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 47, 48, 47, 47, 47, 47, 49, 47, 47, 47, 48, 49, 46, 48, 47, 47, 47, 47, 48, 48, 47, 47, 48, 48, 48, 47, 47, 47, 47, 49, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 48, 47, 47, 48, 48, 47, 46, 47, 47, 48, 47, 48, 47, 48, 47, 47, 47, 47, 48, 48, 48, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 47, 47, 47, 47, 47, 47, 47, 47, 47, 48, 48, 48, 47, 47, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 49, 48, 48, 48, 48, 49, 48, 48, 49, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 47, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 47, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 50, 50, 49, 49, 50, 49, 50, 49, 49, 49, 48, 48, 48, 49, 50, 49, 50, 49, 48, 48, 48, 48, 48, 48, 47, 47, 48, 49, 49, 49, 49, 50, 48, 48, 48, 48, 47, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 49, 48, 49, 48, 48, 49, 49, 48, 48, 49, 48, 48, 48, 49, 49, 48, 48, 49, 48, 48, 48, 49, 48, 50, 49, 48, 47, 48, 48, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 47, 48, 48, 48, 48, 49, 48, 48, 47, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 49, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 49, 48, 48, 48, 49, 48, 49, 48, 47, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 49, 48, 48, 48, 48, 49, 49, 49, 49, 49, 49, 50, 50, 49, 48, 48, 49, 47, 48, 48, 49, 48, 47, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 48, 49, 49, 49, 48, 48, 48, 49, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 49, 48, 48, 49, 48, 49, 48, 49, 48, 48, 48, 49, 47, 48, 49, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 50, 50, 48, 49, 48, 47, 48, 48, 48, 50, 50, 50, 50, 49, 50, 49, 49, 50, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 50, 49, 49, 49, 49, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 50, 50, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 48, 49, 49, 50, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 50, 50, 49, 49, 49, 49, 50, 48, 49, 49, 49, 49, 49, 49, 50, 49, 49, 50, 49, 49, 49, 49, 49, 50, 50, 50, 49, 49, 50, 49, 49, 50, 50, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 51, 50, 50, 50, 50, 51, 51, 51, 52, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 50, 50, 49, 49, 50, 50, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 48, 49, 49, 51, 49, 49, 49, 49, 49, 48, 49, 49, 50, 49, 49, 49, 49, 49, 49, 48, 49, 49, 50, 49, 50, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 50, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 50, 49, 49, 48, 50, 50, 50, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 50, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 50, 49, 49, 50, 49, 49, 48, 49, 49, 50, 50, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 48, 49, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 47, 48, 50, 48, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 49, 48, 49, 48, 48, 48, 49, 50, 49, 49, 49, 49, 50, 50, 49, 50, 49, 49, 49, 49, 49, 49, 49, 48, 49, 49, 48, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 50, 49, 49, 50, 49, 49, 49, 50, 50, 50, 50, 50, 51, 51, 50, 50, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 49, 47, 48, 49, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 49, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 47, 49, 48, 49, 48, 48, 48, 48, 48, 49, 49, 48, 50, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 50, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 49, 49, 48, 48, 48, 48, 49, 50, 48, 48, 48, 48, 47, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 47, 48, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 49, 47, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 47, 48, 47, 47, 48, 48, 49, 47, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 49, 49, 49, 50, 50, 49, 49, 48, 48, 49, 49, 49, 49, 48, 48, 50, 48, 48, 48, 48, 48, 49, 48, 49, 47, 49, 48, 48, 48, 49, 49, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 50, 49, 47, 48, 48, 48, 47, 49, 48, 48, 49, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 50, 48, 48, 48, 48, 49, 48, 48, 49, 49, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 47, 49, 48, 48, 48, 49, 48, 48, 49, 49, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 50, 49, 48, 48, 48, 48, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 49, 49, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 47, 50, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 50, 49, 49, 49, 50, 48, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 48, 49, 49, 49, 49, 50, 50, 50, 50, 49, 48, 49, 49, 49, 50, 50, 49, 49, 49, 50, 50, 49, 49, 49, 49, 51, 49, 48, 48, 49, 48, 49, 50, 49, 49, 49, 49, 49, 49, 50, 50, 50, 49, 49, 49, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 47, 49, 48, 48, 47, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 49, 50, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 50, 49, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 49, 48, 49, 48, 49, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 47, 48, 48, 48, 48, 48, 48, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 47, 48, 48, 49, 48, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 49, 48, 47, 48, 48, 49, 48, 49, 49, 48, 48, 48, 49, 48, 48, 48, 48, 49, 48, 49, 48, 49, 48, 48, 49, 48, 49, 48, 49, 49, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 47, 47, 48, 48, 48, 49, 48, 47, 48, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 48, 49, 47, 47, 48, 47, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 49, 50, 48, 48, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 49, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 49, 48, 48, 49, 48, 48, 48, 49, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 50, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 47, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 49, 48, 48, 48, 48, 50, 47, 49, 48, 49, 48, 49, 48, 48, 47, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 47, 48, 47, 48, 48, 48, 48, 49, 48, 48, 48, 49, 49, 47, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 49, 49, 50, 49, 49, 50, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 47, 49, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 50, 50, 49, 49, 50, 49, 50, 49, 50, 49, 49, 50, 49, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 49, 48, 48, 50, 50, 49, 50, 50, 49, 48, 48, 49, 48, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 50, 49, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 50, 48, 49, 50, 50, 50, 50, 50, 48, 49, 48, 48, 49, 48, 48, 49, 49, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 49, 49, 48, 50, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 47, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 50, 48, 49, 48, 49, 48, 49, 49, 49, 49, 49, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 47, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 49, 48, 48, 48, 49, 48, 48, 48, 49, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 49, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 49, 48, 48, 48, 51, 48, 48, 49, 48, 47, 48, 48, 48, 48, 48, 50, 48, 48, 51, 48, 48, 49, 48, 48, 48, 48, 48, 49, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 49, 48, 48, 48, 49, 49, 48, 49, 49, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 49, 49, 51, 51, 49, 49, 49, 49, 50, 50, 50, 49, 49, 50, 51, 49, 49, 49, 49, 49, 50, 50, 50, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 51, 49, 49, 49, 50, 49, 49, 49, 48, 49, 50, 49, 49, 49, 51, 50, 49, 49, 49, 49, 50, 50, 50, 50, 50, 50, 50, 50, 50, 53, 52, 50, 50, 51, 50, 50, 51, 51, 50, 50, 50, 50, 50, 51, 50, 51, 50, 51, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 49, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 49, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 49, 49, 49, 49, 49, 49, 50, 49, 48, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 49, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 51, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 50, 50, 50, 49, 49, 49, 48, 49, 50, 49, 50, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 49, 50, 50, 49, 49, 49, 49, 50, 48, 50, 49, 49, 49, 51, 49, 49, 49, 48, 49, 49, 48, 49, 49, 50, 50, 49, 49, 49, 49, 49, 49, 48, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 48, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 51, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 50, 49, 51, 49, 49, 49, 49, 48, 49, 49, 49, 50, 49, 49, 49, 49, 49, 50, 49, 48, 49, 48, 48, 48, 48, 50, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 50, 48, 48, 48, 48, 49, 48, 49, 49, 48, 48, 47, 48, 48, 49, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 49, 49, 48, 49, 48, 49, 49, 49, 49, 48, 48, 49, 49, 48, 48, 49, 48, 48, 48, 49, 50, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 50, 48, 48, 48, 49, 48, 48, 49, 48, 48, 48, 48, 47, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 48, 50, 49, 48, 48, 48, 47, 48, 48, 48, 48, 48, 48, 48, 48, 49, 49, 48, 49, 48, 49, 49, 49, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 49, 48, 48, 49, 48, 48, 48, 49, 48, 49, 49, 48, 48, 48, 48, 48, 49, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 49, 48, 48, 48, 48, 48, 48, 48, 48, 48, 47, 48, 48, 50, 50, 49, 49, 51, 49, 49, 49, 50, 49, 48, 49, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 50, 49, 50, 50, 51, 50, 49, 49, 50, 49, 50, 50, 49, 49, 49, 50, 48, 49, 49, 49, 49, 50, 50, 50, 49, 50, 49, 49, 49, 49, 49, 49, 50, 49, 49, 50, 49, 50, 49, 51, 50, 49, 50, 49, 49, 50, 49, 49, 49, 50, 49, 49, 49, 49, 49, 49, 49, 49, 50, 49, 49, 50, 50, 50, 51, 50, 50, 50, 50, 51, 51, 50, 51, 50, 50, 51, 50, 50, 50, 51, 50, 50, 50, 50, 51, 50, 51, 50, 50, 50, 50, 51, 50, 51, 50, 50, 51, 51, 53, 51, 51, 52, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 50, 50, 51, 50, 50, 51, 50, 51, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 50, 51, 50, 51, 52, 50, 50, 50, 50, 51, 50, 53, 50, 50, 51, 51, 51, 50, 51, 50, 50, 50, 50, 51, 52, 51, 50, 50, 51, 51, 50, 50, 51, 50, 50, 50, 50, 49, 50, 50, 50, 50, 51, 49, 50, 50, 50, 50, 50, 51, 51, 50, 50, 50, 50, 51, 51, 51, 50, 50, 51, 52, 51, 52, 51, 51, 51, 51, 51, 51, 53, 51, 51, 51, 50, 50, 51, 50, 50, 50, 50, 50, 50, 49, 50, 51, 50, 49, 50, 50, 51, 51, 50, 50, 50, 50, 50, 51, 51, 50, 51, 50, 50, 50, 50, 50, 50, 50, 51, 50, 50, 50, 50, 50, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 50, 52, 51, 50, 51, 50, 50, 50, 50, 50, 50, 50, 50, 51, 51, 52, 52, 52, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 52, 52, 51, 51, 51, 52, 51, 52, 51, 51, 53, 52, 51, 51, 51, 51, 51, 51, 51, 51, 50, 51, 51, 51, 51, 51, 51, 52, 52, 51, 52, 51, 51, 51, 51, 51, 51, 52, 51, 53, 51, 51, 51, 51, 51, 52, 51, 52, 51, 53, 51, 51, 51, 51, 51, 51, 51, 51, 52, 53, 52, 51, 51, 51, 51, 51, 52, 51, 51, 51, 53, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 52, 53, 52, 53, 52, 52, 50, 51, 51, 52, 51, 51, 52, 51, 51, 50, 51, 51, 51, 51, 51, 51, 51, 51, 52, 52, 52, 51, 51, 51, 51, 51, 50, 51, 51, 51, 52, 51, 51, 52, 51, 52, 52, 52, 52, 52, 52, 51, 51, 51, 51, 52, 52, 51, 51, 52, 51, 51, 50, 51, 50, 51, 51, 51, 51, 52, 51, 52, 51, 50, 51, 51, 51, 51, 52, 51, 52, 51, 51, 52, 52, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 52, 50, 52, 51, 51, 51, 52, 51, 51, 51, 52, 52, 53, 52, 51, 52, 52, 52, 51, 51, 51, 51, 51, 51, 51, 52, 52, 51, 51, 52, 51, 51, 51, 52, 51, 51, 51, 51, 50, 51, 51, 52, 51, 51, 52, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 52, 52, 52, 52, 53, 54, 53, 52, 53, 53, 53, 52, 53, 52, 52, 51, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 52, 51, 52, 52, 52, 52, 51, 52, 52, 52, 53, 51, 51, 51, 51, 51, 52, 53, 51, 52, 52, 52, 51, 52, 52, 51, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 52, 51, 51, 52, 51, 51, 51, 51, 51, 51, 51, 52, 53, 52, 51, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 53, 52, 52, 52, 53, 51, 53, 53, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 53, 52, 52, 51, 51, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 54, 53, 52, 52, 52, 54, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 53, 53, 52, 52, 52, 52, 52, 53, 52, 53, 53, 52, 53, 52, 52, 52, 52, 53, 53, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 53, 52, 52, 53, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 53, 53, 52, 53, 52, 52, 53, 53, 54, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 52, 53, 52, 52, 53, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 54, 53, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 54, 54, 53, 54, 54, 54, 53, 54, 55, 54, 54, 53, 53, 54, 53, 53, 53, 53, 54, 55, 53, 52, 53, 53, 53, 53, 54, 53, 52, 53, 53, 53, 53, 53, 54, 54, 54, 54, 53, 53, 53, 53, 53, 54, 53, 53, 52, 53, 52, 53, 53, 54, 53, 53, 54, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 52, 52, 52, 53, 52, 53, 52, 51, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 51, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 51, 52, 52, 52, 53, 53, 52, 52, 53, 52, 51, 51, 52, 54, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 53, 53, 52, 51, 53, 52, 52, 52, 52, 53, 51, 52, 52, 52, 53, 52, 51, 52, 53, 52, 53, 52, 53, 53, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 54, 52, 53, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 51, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 53, 52, 52, 52, 52, 52, 53, 53, 52, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 54, 52, 52, 52, 52, 53, 51, 52, 52, 52, 52, 52, 53, 52, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 53, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 52, 53, 52, 52, 52, 52, 54, 54, 54, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 55, 52, 53, 53, 53, 52, 53, 54, 54, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 52, 53, 53, 53, 55, 53, 52, 53, 53, 53, 53, 53, 53, 54, 52, 53, 53, 54, 53, 53, 53, 52, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 53, 54, 52, 52, 53, 54, 52, 53, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 52, 53, 53, 53, 54, 53, 53, 53, 52, 53, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 53, 53, 54, 52, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 53, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 55, 55, 55, 55, 55, 55, 56, 55, 53, 54, 54, 53, 54, 54, 54, 54, 55, 54, 54, 53, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 54, 55, 54, 54, 54, 54, 55, 56, 55, 54, 54, 54, 55, 54, 54, 54, 54, 54, 54, 54, 53, 54, 54, 54, 54, 54, 55, 54, 54, 54, 54, 54, 54, 54, 54, 55, 55, 55, 53, 54, 54, 55, 55, 55, 54, 54, 54, 54, 54, 55, 55, 54, 54, 55, 55, 55, 55, 54, 54, 54, 54, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 54, 53, 53, 53, 53, 53, 52, 54, 54, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 54, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 53, 53, 53, 54, 54, 53, 54, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 55, 54, 54, 52, 53, 53, 53, 53, 53, 53, 54, 53, 54, 53, 53, 54, 53, 53, 53, 53, 53, 54, 53, 54, 53, 53, 53, 53, 53, 53, 53, 53, 54, 53, 53, 53, 54, 54, 55, 54, 54, 55, 54, 55, 55, 54, 54, 53, 53, 53, 53, 52, 53, 53, 53, 54, 53, 53, 54, 53, 53, 53, 53, 53, 53, 52, 53]
Topic Token Allocation Count (sum=7.68434972E8):
[45235668, 36982433, 30075818, 26600528, 25145099, 24763176, 24729593, 24583837, 24085489, 23441202, 23215069, 22997466, 22818963, 20869523, 20590572, 20572160, 19393773, 18793683, 18446460, 18294789, 18129591, 17565300, 15863681, 15576536, 14746150, 14595011, 14585933, 14442427, 14049480, 13278774, 12444624, 12305363, 11780000, 11675979, 11369952, 11315336, 10288662, 9109410, 8759113, 7499395, 6075158, 4499052, 4135665, 1146689, 969657, 591782, 773, 98, 32, 28, 10, 9, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
Topic Token Allocation Count (%):
[0.0589, 0.0481, 0.0391, 0.0346, 0.0327, 0.0322, 0.0322, 0.0320, 0.0313, 0.0305, 0.0302, 0.0299, 0.0297, 0.0272, 0.0268, 0.0268, 0.0252, 0.0245, 0.0240, 0.0238, 0.0236, 0.0229, 0.0206, 0.0203, 0.0192, 0.0190, 0.0190, 0.0188, 0.0183, 0.0173, 0.0162, 0.0160, 0.0153, 0.0152, 0.0148, 0.0147, 0.0134, 0.0119, 0.0114, 0.00976, 0.00791, 0.00585, 0.00538, 0.00149, 0.00126, 0.000770, 0.00000101, 0.000000128, 0.0000000416, 0.0000000364, 0.0000000130, 0.0000000117, 0.00000000130, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000, 0.0000]
Topic Token Allocation CDF (%):
[0.0589, 0.1070, 0.1461, 0.1807, 0.2135, 0.2457, 0.2779, 0.3099, 0.3412, 0.3717, 0.4019, 0.4319, 0.4616, 0.4887, 0.5155, 0.5423, 0.5675, 0.5920, 0.6160, 0.6398, 0.6634, 0.6862, 0.7069, 0.7272, 0.7463, 0.7653, 0.7843, 0.8031, 0.8214, 0.8387, 0.8549, 0.8709, 0.8862, 0.9014, 0.9162, 0.9309, 0.9443, 0.9562, 0.9676, 0.97733, 0.98524, 0.99109, 0.99647, 0.99797, 0.99923, 0.999999, 0.99999977, 0.999999896, 0.9999999375, 0.9999999740, 0.9999999870, 0.9999999987, 1.00000000000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000, 1.0000]
Fri May 24 04:15:45 BST 2019: I am done!
Build info:Implementation-Build = 21f3fa031204320aa15d4613c5a67a1c833b26e8, Implementation-Version = 8.0.6
